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ABSTRACT
AIDS is characterised by a progressive depletion of CD4^ helper T lymphocytes. 
This process has been shown to involve apoptosis. Several studies have demonstrated 
that apoptosis can be induced in both infected and non-infected cells by the HIV-1 
gpl20 surface glycoprotein. Thus, crosslinking of CD4 by gpl20 and anti-gpl20 
antibodies, or specific anti-CD4 antibodies induces apoptosis in uninfected T cells 
which is partially mediated via sensitization to CD95(Apo-l/Fas) -mediated cell death. 
It has recently been shown that gpl20 induces a novel type of apoptosis in T cells. This 
was induced via both the CD4 and CXCR4 receptors and was CD95 and caspase 
independent.
The work described in this thesis investigated the role of CD4 and CXCR4 
induced apoptosis as a potential indirect mechanism of T-cell depletion during HIV-1 
infection. The relative contribution of the „classical" or „novel“ apoptotic pathways 
engaged by these receptors, upon cell death induction, were investigated in the in vivo 
situation. Data in this thesis demonstrate that peripheral blood lymphocytes (PBLs) 
from a representative cohort of HIV-1 infected individuals show higher sensitivity to 
CD4 and CXCR4 mediated apoptosis compared to PBLs from healthy controls. 
Activation of PBLs from healthy individuals rendered, however, these cells susceptible 
to CD4 and CXCR4 mediated apoptosis. This supports the hypothesis that the 
sensitivity of PBLs from HIV-1 infected individuals to CD4 and CXCR4 mediated 
apoptosis is due to the immune hyperactivation occuring during the course of the 
infection.
The signaling mechanism of the novel type of cell death was also investigated 
focusing primarily on CD4 mediated apoptosis. Studies on CD4 mutant receptors 
showed that the cytoplasmic tail of CD4 is dispensable for the induction of cell death. 
Preliminary biochemical analysis also failed to detect recruitment of signaling 
molecules to the CD4 receptor complex. These findings strongly suggest that a 
molecule adjacent to the CD4 receptor or the CXCR4 receptor may be responsible for 
the transmission of the apoptotic signal. Studies on the role of mitochondria during CD4 
mediated apoptosis showed release of both cytochrome c and AIF. This suggests a
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central role for mitochondria in the CD4 induced, caspase independent apoptotic 
signaling pathway.
Improvement of our understanding of the mechanisms of HIV-1 associated 
lymphocyte apoptosis, as well as the signaling cascades involved, may lead to 
therapeutic strategies aimed at intervening with the CD4+ T cell depletion in HIV-1 
infected individuals.
Introduction
I INTRODUCTION
1 Apoptosis
1.1 Definition of apoptosis
Programmed cell death was discovered by C.Vogt in the middle of the 19'” 
century (Vogt, 1842) by the morphology of dying cells during the metamorphosis in 
amphibians. In more than hundred years after the initial description, programmed cell 
death was rediscovered many times. The term „apoptosis“ was originally used by Kerr 
et al (1972) to describe the morphological characteristics of a certain type of cell death 
as opposed to necrosis. During necrosis, the cell swells, its mitochondria dilate, other 
organelles dissolve and the plasma membrane ruptures releasing cytoplasmic material; 
this often elicits an inflammatory response.
In contrast, during apoptosis, the cytoplasm shrinks and the chromatin 
condenses, but the organelles retain their integrity. The plasma membrane blebbs and 
exposes phosphatidyl serine on its outer surface, which is normally retained in the inner 
leaflet. However, the plasma membrane does not rupture preventing the release of 
cellular compounds into the extracellular medium. In vitro, apoptotic cells ultimately 
fragment into membrane-enclosed vesicles (apoptotic bodies), whereas, in vivo, they are 
recognised and removed by phagocytes, thereby avoiding inappropriate inflammation. 
Biochemical hallmarks of apoptosis include the activation of endonucleases, DNA 
degradation into oligonucleosomal fragments and the activation of a family of cysteine 
proteases called caspases.
Currently, the term apoptosis is used as a synonym of programmed cell death. 
However, there is accumulating evidence to indicate the existence of genetically 
programmed cell death pathway(s) that lack certain morphological or biochemical 
hallmarks of classical apoptosis. This suggests that one needs to take a larger view of
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the meaning of the word „apoptosis“. The simple original definition of apoptosis needs 
to be re-evaluated in order to avoid semantic confusion.
1.2 The role of apoptosis in the immune system
Apoptosis is the most common form of death in cells of the immune system. A 
pivotal process during lymphoid development is the education of immature lymphoid 
populations to discriminate between self and non-self. In the case of the T cell lineage, 
immature thymocytes can be positively selected and exit the thymus to populate the 
peripheral immune system. Alternatively, autoreactive thymocytes are negatively 
selected and die within the thymus by apoptosis. Similarly, negative selection also takes 
place in immature B cells in the bone marrow, leading to the elimination of self-reactive 
B-cell clones.
In the periphery, it is necessary to control proliferation of activated lymphocytes 
to prevent the accumulation of high levels of cytokines, potentially deleterious to the 
organism. In the case of T cells, activated cells are induced to undergo apoptosis which 
prevents the accumulation of toxic levels of cytokines. Increasing evidence suggests that 
B-cell homeostasis is also maintained by the removal of activated cells by apoptotic 
mechanisms. In addition to the contribution of apoptosis in the homeostatic control of T 
and B cell populations, it is also important in the effector function of cytotoxic T cells 
(CTLs), as these cells kill target cells by the induction of apoptosis in the target. 
Moreover, autoreactive T lymphocytes which have escaped negative selection in the 
thymus are eliminated by apoptosis, thus ensuring self-tolerance of the organism.
There are many different pathways via which immune cells can choose to die. In 
principle, death can be by neglect when the antigen specific receptors of the lymphoid 
cells are not stimulated or the lymphocytes are deprived of trophic cytokines. In a more 
active form, death can involve the death-receptor/death-ligand systems (Krammer, 
2000).
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2 The „death receptors‘‘
Death receptors belong to the tumor necrosis factor (TNF) receptor gene 
superfamily, which is defined by similar cysteine-rich extracellular domains (Smith et 
ah, 1994). The death receptors contain in addition a homologous cytoplasmic sequence 
termed the „death domain'' (Tartaglia et ah, 1993; Nagata et al., 1997). Death domains 
typically enable death receptors to engage the cell's apoptotic machinery, but in some 
instances they mediate functions that are distinct from or even counteract apoptosis.
The best characterised death receptors are CD95 (also called Apo-1 or Fas) and 
TNFRI (also called p55 or CD 120a) (Trauth et al., 1989; Yonehara et ah, 1989; 
Loetscher et ah, 1990; Schall et ah, 1990). Additional death receptors are Apo-3 (also 
called DR3, WSL-I, TRAMP or LARD), TRAIL-RI (DR4), TRAIL-R2 (also called 
Apo-2, DR5, TRICK2 or KILLER), DR6 and the avian CARl (Chinnaiyan et ah, 1996; 
Kitson et ah, 1996; Marsters et ah, 1996; Pan et ah, 1997a; Walczak et ah, 1997; Pan et 
ah, 1997b; Sheridan et ah, 1997; Screaton et ah, 1997a; Schneider et ah, 1997; Pan et 
ah, 1998; Brojatsch et ah, 1996). The ligands that activate these receptors are 
structurally related molecules that belong to the TNF gene superfamily (Smith et ah,
1994). CD95 ligand (CD95L) binds to CD95, TNFa and lymphotoxin a  binds to 
TNFRI, Apo-3 ligand (Apo-3L also called TWEAK) binds to DR3 and TRAIL (also 
called Apo-2 ligand) binds to TRAIL-RI and TRAIL-R2 (Chicheportiche et al., 1997; 
Marsters et al., 1998; Wiley et ah, 1995; Pan et al., 1997b; Sheridan et al., 1997).
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Fig. I.l: Schematic representation of the death receptors and their 
ligands. The cysteine rich extracellular domains are depicted in blue while 
the intracellular death domains are depicted in red.
The CD95 signal transduction pathway: a paradigm of classical 
caspase dependent apoptosis
Triggering of CD95 leads to trimérisation of the receptor which is required for 
transduction of the apoptotic signal. A complex of proteins associates with the activated 
receptor thus forming the „death inducing signaling complex" (DISC) (Kischkel et al.,
1995). The adaptor molecule F ADD (CAP 1/2, MORTl) binds via its own death 
domain to the death domain in CD95 (Chinn et al., 1995; Boldin et al., 1995). F ADD 
also carries a death-effector domain (DED) and again by homologous interaction 
recruits the DED-containing procaspase-8 (also known as FLICE, MACH, Mch5) 
(Muzio et al., 1996). Next, procaspase-8 is activated proteolytic ally and active caspase- 
8 is released into the cytoplasm where it initiates a protease cascade.
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3.1 The caspase cascade
Caspase-8 belongs to a growing family of cysteine proteases (Alnemri et al.,
1996) which are crucial for the execution of apoptosis. Caspases are synthesized as 
proenzymes that are activated by proteolytic cleavage.
So far 11 human caspases are known which can be subdivided into three 
subgroups on the basis of their substrate specificity (Thomberry et al., 1997). Group 1 
includes caspases -1, -4, -5  and -13 which are not implicated in apoptosis but have a 
role in cytokine processing during inflammation. Group 11 consists of caspases -2, -3 
and -7. The preferred cleavage motif for group 11 caspases appears in many proteins 
that are cleaved during cell death, consistent with group 11 being the major effectors of 
cell death. Group 111 include caspases -6, -8, -9 and -10. The cleavage motif for group 
111 caspases is found at the maturation site of most group 11 and group 111 caspases. This 
specificity is consistent with the group 111 enzymes being upstream activators of the 
group 11 effector caspases.
This molecular ordering is exemplified by the caspase-8-mediated activation of 
caspase-3 and -7  in the CD95 signal transduction pathway (Slee et al., 1999).
Apoptosis can be blocked via caspase-specific inhibitors. Naturally occuring 
inhibitors include the baculovirus p35 protein (Kamita et al., 1993; Beidler et al., 1995) 
and the cowpox virus serpin CrmA (Gagliardini et al., 1994; Komiyama et al., 1994). 
The synthetic tripeptide z-Val-Ala-Asp.fiuoromethylketone (zVAD.fmk) and the related 
compound t-butoxy carbonyl-Asp.fluoromethylketone (BD.fmk) have been described as 
broad range caspase inhibitors (Sarin et al., 1996; Brown et al., 1998). Due to an 
aspartate residue mimicking the cleavage site and an fmk group forming a covalent 
inhibitor/enzyme complex, these inhibitors instantly and irreversibly bind to the 
catalytic site of caspases (Garcia-Calvo et al., 1998; Thomberry et al., 1997).
Although zVAD.fmk is known to block all so far known caspases (Garcia-Calvo 
et al., 1998), one cannot exclude that yet unidentified caspases are resistant to this drug. 
It is not known whether the inhibitor is sufficiently stable inside cells. Moreover, methyl 
ketone peptide inhibitors have been reported to non-specifically inhibit other cysteine
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proteases, such as calpain and cathepsin B (Waterhouse et al., 1998; Schotte et al., 
1998).
3.2 The role of mitochondria
In so-called type 1 cells, the CD95 induced death signal is propagated by 
activation of large amounts of caspase-8 at the DISC, followed by cleavage of caspase - 
3 and -7 which in turn cleave vital substrates in the cell. In certain cell types, however, 
hardly any DISC is formed, so the caspase cascade cannot be propagated directly. These 
cells (called type 11 cells) use the mitochondria as amplifiers to initiate the executionary 
apoptosis caspase cascade (Scaffidi et al., 1998). Activation of mitochondria is 
mediated by the pro-apoptotic BH3-only Bcl-2 family member Bid. Bid is a substrate of 
caspase-8 which is activated in low amounts at the DISC (Luo et al., 1998; Li et al., 
1998). Truncated Bid translocates to the mitochondria and induces loss of mitochondrial 
transmembrane potential (A'Fm) and release of apoptogenic factors such as cytochrome 
c (Kroemer, 1995). Together with the apoptosis protease-activating factor Apaf-1 and 
procaspase-9 in the cytoplasm, these molecules form a complex called apoptosome 
(Zou et al., 1997; Li et al., 1998). At the apoptosome pro-caspase-9 is autocatalytically 
processed to the mature enzyme and initiates a caspase cascade downstream of the 
mitochondrion (Srinivasula et al., 1998; Zou et al., 1999).
3.3 The death substrates
Activation of caspases does not result in the wholesale degradation of cellular 
proteins. Rather, caspases selectively cleave a restricted set of target proteins. Several 
important caspase substrates have been identified in recent years. Molecules involved in 
DNA repair, such as poly(ADP-ribose) polymerase (PARP) or the catalytic subunit of 
the DNA-dependent protein kinase (DNA-PK), were described to be cleaved and 
thereby inactivated by downstream caspase-3 like caspases (Lazebnik et al., 1994; Gu et 
al., 1995a; Casciola-Rosen et al., 1995; Song et al., 1996b). The ribonucleoproteins U l- 
70kDa, Cl and C2, components responsible for the splicing reaction of precursor
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mRNA are inactivated by cleavage through caspases (Casciola-Rosen et al., 1994; 
Tewari et al., 1995a; Waterhouse et al., 1996).
Another set of death substrates are structural proteins of the cell. Cleavage of 
these proteins may account for several of the characteristic morphological features of 
apoptosis. Thus, cleavage of the nuclear lamins may be required for nuclear shrinking 
and budding (Rao et al., 1996; Buendia et al., 1999). Loss of overall cell shape is 
probably caused by the cleavage of cytoskeletal proteins such as actin, fodrin and 
gelsolin ( Mashima et al., 1995; Kothakota et al., 1997).
Moreover, the nuclease that cuts the genomic DNA during apoptosis, to 180 bp 
fragments, thus leading to DNA ladder formation, is activated by caspase 3. The 
nuclease (now known as caspase-activated DNase, or CAD or DFF40) pre-exists in 
living cells as an inactive complex with an inhibitory subunit, dubbed 1C AD (Nagata et 
al., 2000). Activation of CAD occurs by means of caspase-3 mediated cleavage of the 
inhibitory subunit, resulting in the release and activation of the catalytic subunit (Liu et 
al., 1997; Enari et al., 1998 ).
4 Caspase independent apoptosis
Since caspases are considered as the main effectors of apoptotic cell demise 
there is a tendency to conceptually identify apoptosis with its main execution system. It 
is unlikely that a single execution system is solely responsible for apoptosis. Should this 
be the case, viruses and transformed cells could have easily escaped or shut down a 
programme converging on a single execution pathway (Nicotera et al., 2000). Moreover 
it is difficult to conceive how the plethora of signals causing apoptosis would converge 
on a single linear pathway. Thus additional interelated or independent pathways may 
have developed to regulate death.
McCarthy et al. reported that while cells treated with z-VAD.fmk or BD.fmk did 
not display cleavages of caspase substrates, chromatin condensation or nucleosomal 
laddering in response to oncogenic and DNA damaging apoptotic stimuli, they
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continued to exert other apoptotic features such as cell shrinkage and membrane 
blebbing and could not be rescued from the death fate. This suggested that certain 
cytoplasmic hallmarks of apoptosis may be triggered by enzymes other than caspases, 
but that the nuclear events required caspase activity.
Several studies support the existence of caspase independent apoptotic pathways. 
These include apoptosis induced via the CD4 and CXCR4 receptors (Bemdt et al., 
1998), class IMHC antibodies (Woodle et al., 1997), the GD3 ganglioside (De Maria et 
al., 1997), CD2 and staurosporine (Deas et al., 1998), intracellular acidification (Zanke 
et al., 1998), CD47 (Pettersen et al., 1999), puromycin (Schlapbach et al., 1997), 
polyamine analogues (Ha et al., 1998), the retinoid AHPN (Adachi et al., 1998), E4orf4, 
a novel adenovirus death factor (Lavoie et al., 1998), VP-16, dexamethasone and 
actinomycin-D (Amarante-Mendes et al., 1998, Brunet et al., 1998, Benson et al., 
1998), PML (Quignon et al., 1998) and NO (Okuno et al., 1998). Even some aspects of 
CD95-induced apoptosis may occur caspase-independently, using the kinase RIP as 
effector molecule, although in this case necrotic morphologies were observed (Holler et 
al., 2000). Moreover a nonapoptotic form of programmed cell death, dubbed paraptosis, 
has been recently described. Although this type of cell death was not inhibited by 
caspase inhibitors, it was driven by an alternative caspase-9 activity that was Apaf-1 
independent (Sperandio et al., 2000).
4.1 Caspase-independent apoptosis effectors
The cellular components involved in caspase-independent apoptosis remain 
elusive. In most apoptotic systems zVAD.fmk does not block mitochondrial changes 
such as loss of mitochondrial transmembrane potential, production of oxygen radicals 
and the release of apoptogenic factors (Green and Reed, 1998; Kroemer, 1998). The 
recently discovered mitochondrial membrane protein AIF (apoptosis inducing factor) 
has been proposed as a caspase-independent apoptotic effector (Susin et al., 1999). In 
addition, Bax and Bax-like proteins, pro-apoptotic homologues of the Bcl-2 family may 
also be important in this process (Adams and Cory, 2001).
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4.1.1 AIF
AIF has been recently identified as a mitochondrial interspace membrane protein 
with homology to bacterial NADH oxidoreductases. If microinjected into the cytoplasm 
of normal cells, recombinant AIF causes three hallmarks of apoptosis, namely the 
dissipation of the mitochondrial transmemrane potential and the release of cytochrome 
c, the condensation of nuclear chromatin, and the exposure of phosphatidyl serine on the 
plasma membrane surface. These alterations are rapid and are not prevented by addition 
of the broad spectrum caspase inhibitor z-VAD.fmk or overexpression of the anti- 
apoptotic protein Bcl-2 (Susin et al., 1999; Ferri et al., 2000). In cell free systems, 
addition of recombinant AIF to purified nuclei causes chromatin condensation which is 
accompanied by large scale DNA fragmentation but not by oligonucleosomal DNA 
fragmentation.
When cells are induced to undergo apoptosis, AIF is released from mitochondria 
to the cytosol and to the nucleus. Kinetic studies have shown that the release of AIF 
coinsides with the dissipation of the mitochondrial transmembrane potential and 
precedes the release of cytochrome c. Moreover, early caspase independent signs of 
nuclear apoptosis such as rippled nuclear contours and a partial chromatin condensation 
seem to involve the translocation of AIF from mitochondria to the nucleus (Daugas et 
al., 2000).
4.1.2 Bax-like proteins
The Bcl-2 protein family comprises 15 members which play an important role in 
the regulation of cell survival and apoptosis. These molecules can be subdivided into 
three groups: the Bcl-2 subfamily which promotes cell survival and the Bax and BH3 
subfamilies which facilitate apoptosis (Adams and Cory, 1998). Bax is both a 
membrane and cytoplasmic protein and there is increasing evidence that the cytoplasmic 
form undergoes a conformational change and translocates to mitochondrial membranes 
in response to apoptotic stimuli. In the presence of a caspase inhibitor, overexpression
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of Bax-like proteins provoke cell death accompanied by DNA condensation and 
membrane alterations but no caspase activation or DNA degradation (Xiang et al., 1996; 
Gross et al., 1998). Bax and Bax-like proteins might mediate caspase independent death 
via channel-forming activity which could promote the mitochondrial permeability 
transition or puncture the mitochondrial outer membrane thus leading to release of 
apoptogenic factors (Green and Reed, 1998).
4.1.3 Non-caspase proteases
Caspase independent apoptotic factors may exert their effect by activating other 
proteases such as serine proteases, calpains and cathepsins. A recent report has shown 
that any type of protease, when loaded into cells, can provoke apoptosis like 
morphology (Williams et al., 1994). Serine proteases have been reported to play a 
crucial role in the early cleavage of chromatin into 50-300 Kb fragments before they are 
digested to nucleosome-sized pieces by CAD (Hughes et al., 1998). Moreover, the 
serine protease granzyme A may mediate caspase-independent CTL/target cell lysis 
(Chang et al., 1980).
Calpains have been shown to participate in apoptosis in response to several 
stimuli (Borner and Monney, 1999). Since they are calcium requiring enzymes they 
may be activated in response to increased cytoplasmic calcium levels, for example due 
to mitochondrial damage (Berridge et al., 1998). In addition, lysosomal proteases such 
as cathepsin D have been implicated in INF-y, CD95 and TNFa induced apoptosis 
(Deiss et al., 1996).
Introduction____________________________________________________________13
5 Immunopathology of HIV-1 infection
The type 1 human immunodeficiency virus (HIV-1) is a lentivirus of the family 
Retroviridae. HIV-1 is the causative pathogenic agent of the acquired immune 
deficiency syndrome (AIDS). Clinically, HIV-1 infection may be divided into three 
phases: primary infection, asymptomatic period and clinical immunodeficiency.
Initial (acute) infection with HlV-1 results in clinical symptoms within one to 
three weeks in at least half of those newly infected. These symptoms are similar to 
influenza infection or mononucleosis, along with a non-pruritic macular erythematosus 
rash (Fox et al., 1987). During symptomatic primary infection, levels of infectious virus 
and of infected cells in the circulation are both very high and a substantial reduction in 
CD4+ T-cell numbers is observed (Daar et al., 1991; McMichael and Phillips, 1997).
Shortly after acute infection, most patients undergo seroconversion. This stage is 
associated with a dramatic downregulation in the levels of virus replication as 
determined by plasma viraemia and titers of infectious virus, and an increase in CD4+ 
T-cell numbers back to normal levels (more than 1000 cells/jil blood) (Pantaleo et al., 
1994). This coinsides with the emergence of HIV-specific immune responses. Virus- 
specific cytolytic T lymphocytes (CTL) appear early and may represent a critical host 
factor in the control of primary HIV-1 infection (Borrow et al., 1994; Pantaleo et al., 
1994). The combined effects of CTL and other elements of the immune response (such 
as NK cells and humoral immune response) cause the amount of virus in the blood to 
decrease, however, sterilizing immunity is never achieved.
The next phase of HIV-1 infection is the long asymptomatic period between 
primary infection and the development of clinical immunodeficiency. This period of 
clinical latency may last from six months to more than fifteen years (Buchbinder et al., 
1994). There are two related pathophysiologic characteristics of the asymptomatic 
phase: ongoing viral replication in the peripheral lymphoid tissues and gradual loss of 
CD4+ T cells. The rate of decline in CD4+ T cells appears to be determined by the level 
of ongoing viral replication, as patients with higher plasma virus set points progress to 
AIDS more rapidly (Mellors et al., 1996).
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The final phase of the infection is characterized by the emergence of clinical 
immunodeficiency. In the year or two before AIDS develops, there is often a more rapid 
decline in CD4+ T cells. This decline may be preceded by an increase in viral load 
(Connor et al., 1993). As the CD4 count falls below 200 cells/|il opportunistic infections 
or cancers begin to occur (Castro et al., 1993). The degree of CD4 decline is an 
excellent predictor of the risk for particular infections, providing strong support for the 
notion that the loss of CD4+ T cells is the central cause of immunodeficiency in this 
disease (Pierson et al., 2000).
6 The role of chemokine receptors In HIV-1 infection
HIV-1 enters target cells by direct fusion of the viral and target membranes. The 
fusion reaction is mediated by the viral envelope glycoprotein (Env), which binds with 
high affinity to CD4, the primary receptor on the target cell surface. The notion that a 
coreceptor is required for HlV-1 entry stemmed from the awareness that CD4 
expression is not sufficient to explain HlV-1 tropism for different target cells in vitro 
(Berger et al., 1997). This led to the identification of the CXCR4 and CCR5 chemokine 
receptors, members of the G protein-coupled receptor superfamily as the principal 
coreceptors for HlV-l entry (Feng et al., 1996; Raport et al., 1996).
The type of chemokine receptor which the virus is able to use depends on the 
sequence of its gpl20. The V3 loop of gpl20 is particularly important in determining 
coreceptor usage (Touchier et al., 1992). The viral DNA encoding this region is highly 
variable and also mutates during the course of infection thus allowing the virus to 
change its coreceptor usage and, therefore, phenotype. However, conserved regions of 
gpl20 have also been shown to be important in binding to chemokine receptors (Verrier 
et al., 1997).
Macrophage-(M)-tropic viruses, which represent the predominant virus 
population early after infection, use the CCR5 receptor to enter primary CD4+ T cells
Introduction____________________________________________________________15
and macrophages (R5 viruses). Lab adapted strains grown for many passages on T cell 
lines use CXCR4 as a coreceptor. Although CXCR4 is present on both macrophages 
and T cells, most T-cell line adapted viruses can only use CXCR4 on primary T cells or 
T cell lines, the CXCR4 coreceptor on macrophages appears to be unavailable for 
binding in this case (Yi et al., 1999). Dual tropic viral strains which can use both CCR5 
and CXCR4 are able to infect both macrophages and T cells. CXCR4 using (X4) viruses 
and/or viruses with dual tropism (R5/X4) typically emerge later in disease in temporal 
association with rapid CD4+ T cell decline and progression to AIDS (Connor et al., 
1997; Goudsmit et al., 1995; Xiao et al., 1998).
Additional complexity results from the findings that HlV-1 coreceptor activity is 
not limited to CXCR4 and CCR5. Coreceptor activity has been also demonstrated for 
several other chemokine receptors such as CCRl, CCR2b and CCR3 (Choe et al., 1996; 
Doranz et al., 1996).
The realization that CCR5 is the molecular factor mediating entry of the 
preferentially trasmitted M-tropic HlV-1 variants led to a focus on this receptor as a 
possible determinant of transmission. Evidence came from the discovery of a mutant 
CCR5 allele designated CCR5 A32 and the association of this allele with resistance to 
HlV-1 infection. CCR5 A32 has a 32 base pair deletion leading to a truncated protein 
product which is not expressed on the cell surface (Liu et al., 1996; Martinson et al., 
1997). The mutant allele is common in Caucasians, heterozygotes and homozygotes 
represent ~ 20% and -1% of this population, respectively. Homozygocity for A32 does 
not confer a selective disadvantage on healthy individuals, suggesting that normal 
CCR5 function is dispensable. It confers however a protective effect on transmission of 
HlV-1 (Connor et al., 1996; Rana et al., 1997). Rare HlV-1 infected A32/A32 
individuals have been reported, thus demonstrating that CCR5 is not absolutely required 
for HlV-1 transmission and raising the speculation that CXCR4 was the coreceptor 
responsible for initiating infection (Biti et al., 1997; O'Brien et al., 1997; Theodorou et 
al., 1997).
Chemokine coreceptor and chemokine genetic polymorphisms have also been 
correlated with HlV-1 disease progression. Thus, A32 heterozygocity has been
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correlated with delayed progression to AIDS and shows a higher genotypic frequency in 
cohorts of long term nonprogressors (Dean et ah, 1996). In addition, another CCR5 
gene polymorphism, CCR5 59029 G/A, as well as a CCR2 gene polymorphism, CCR2- 
641, correlate with slower disease progression (McDermott et ah, 1998; Smith et ah,
1997). Like CCR5 A32, CCR2-641 is enriched among long-term non progressors and 
reduced in rapid progressors (Smith et ah, 1997).
A genetic polymorphism, designated SDF-1 3‘A, has also been identified in one 
of the two known chemokine ligand for CXCR4, SDF-1 p. SDF-1 3‘A is found in all 
racial groups tested and homozygote individuals represent ~ 5% of Caucasians. A 
strong association has been described between the homozygous 3‘A/3‘A genotype and 
delayed onset of AIDS while the effect was reported to be increased in later stages of 
HlV-1 infection (Winkler et ah, 1998).
7 The role of apoptosis In the pathogenesis of HIV-1 infection
7.1 Apoptosis as the basis of CD4+ T-cell depletion during HIV-1 infection
Although CD4+ T-cell production is impaired in HlV-1 infected patients 
(Hellerstein et ah, 1999), there is currently overwhelming evidence that the primary 
basis of T-cell depletion is increased apoptosis of CD4+ and CD8+ T cells (Gougeon et 
ah, 1996; Badley et ah, 2000). Because HlV-1 is cytopathic for T cells in vitro, it was 
originally presumed that direct viral cytopathic effects were responsible for T cell 
depletion (Heeney, 1995). However, subsequent studies have shown that only a minor 
fraction of lymphocytes (<0.01%) is physically infected by HlV-1 (Chun et ah, 1997; 
Simmonds et ah, 1990). Moreover, HlV-1 infected individuals experience a loss of 
CD 8+ T-cells, NK cells and neurons although these cells are not infected by HlV-1 
(Gougeon et ah, 1996; Oyaizu and Pahwa, 1995). Therefore, cytopathic effects of the 
virus due to direct infection cannot solely account for the enhanced apoptosis of
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lymphocytes seen in infected persons. This indicated that other indirect mechanism(s) 
are involved.
7.1.1 Indirect mechanisms of HIV-associated apoptosis
Finkel et al. showed in HIV-1 infected children and simian immunodeficiency 
virus-infected macaques that predominantly non-infected cells are eliminated by 
apoptosis. In addition, infected and non-infected T cells from HIV-1 infected 
individuals show enhanced spontaneous apoptosis in vitro and are more sensitive to 
activation-induced cell death (AICD) than T cells from non-infected subjects (Groux et 
al., 1992; Meyaard et al., 1992; Gougeon et al., 1993). Enhanced sensitisation is 
paralleled by enhanced expression of CD95 and its ligand (CD95L) and by enhanced 
sensitivity to CD95 mediated apoptosis (Debatin et al., 1994; Baumler et al., 1996). 
Moreover, T cells from HIV-1 infected individuals show susceptibility to TRAIL 
mediated apoptosis in contrast to T cells from healthy control subjects (Jeremias et al.,
1998). The TRAIL system may also contribute to the enhanced T-cell AICD observed 
in HIV-1 positive individuals (Katsikis et al., 1997). A recent study, using an HIV-1 
infection mouse model, also suggests that large numbers of uninfected CD4+ T cells 
undergo TRAEL-mediated apoptosis (Miura et al., 2001).
7.1.2 Apoptosis induced by HIV-1 encoded proteins
Although the aberrant immune activation occuring during HIV-1 infection can 
lead to lymphocyte apoptosis, considerable data indicate that there are additional 
distinct mechanisms by which HIV-1 induces apoptosis (Badley et al., 2000). Indeed 
several HIV-1 encoded proteins such as Tat, Nef and Vpr have been implicated in 
enhancement or direct induction of apoptosis. Tat may induce apoptosis in uninfected T 
cells by altering the redox state and by CD95 dependent mechanisms (Westendorp et 
al., 1995). Recently; Tat has been also shown to upregulate TRAIL in macrophages, 
which could then induce apoptosis of bystander T cells (Zhang et al., 2001). Nef has 
also been suggested as a potential mediator of CD95-independent apoptosis (Okada et 
al., 1997). In addition, Vpr has been shown to induce apoptosis via a direct effect on 
mitochondrial permeability (Jacotot et al., 2000) and via induction of cell cycle arrest 
(Stewart et al., 1997).
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7.1.2.1 Gpl20-induced apoptosis
The HIV-1 envelope glycoprotein gpl20, which binds and crosslinks the CD4 
receptor and the chemokine coreceptors, has also been described as a potent inducer of 
apoptosis (Laurent-Crawford et al., 1993; Corbeil et al., 1995; Ohnimus et al., 1997). 
HIV-1 envelope interaction with CD4 can induce apoptosis of HIV-1 infected T cells 
via caspase activation but independently of CD95 and Bcl-2 (Gandhi et al., 1998; 
Kolesnitchenko et al., 1997). Crosslinking of CD4 by gpl20 and anti-gpl20 antibodies, 
or specific anti-CD4 antibodies, also induces apoptosis in uninfected T cells. This is 
partially mediated via sensitization to CD95-mediated cell death (Banda et al., 1992; 
Westendorp et al., 1995).
The recent discovery of the chemokine coreceptor CXCR4 prompted the 
investigation of its role in HIV-1 envelope induced apoptosis. Indeed several reports 
have implicated CXCR4 in gpl20 induced apoptosis. Thus, Hesselgesser et al. reported 
that gpl20 induced neuronal apoptosis is mediated by CXCR4. Cell surface expressed 
HIV-1 envelope also triggered apoptosis in CXCR4 transfected HEK-293 cells, in a 
caspase dependent manner (Biard-Piechaczyk et al., 2000). Blanco et al. reported that 
HIV-1 envelope induced apoptosis in syncytium-forming and in single uninfected 
lymphocytes was blocked by a CXCR4 antagonist. In addition, infection of 
lymphocytes and lymphoid tissue with CXCR4 dependent HIV-1 led to depletion of 
CD4 positive T cells thus suggesting a critical pathogenic role for gpl20-CXCR4 
interactions (Penn et al., 1999).
Recent studies have shown that stimulation of CD4 and CXCR4 via gpl20 
crosslinked by anti-gpl20 antibodies, or via specific anti-CD4 and anti-CXCR4 
antibodies, induces a novel type of apoptosis in T cells (Bemdt et al., 1998). This new 
type of cell death showed rapid kinetics, was independent of caspases and did not 
involve the CD95-, TNF- and TRAIL-death systems. Although oligonucleosomal DNA 
degradation (a hallmark of classical apoptosis) was not observed several characteristic 
features of apoptotic cell death were detected, such as cytoplasmic and chromatin 
condensation, integrity of plasma membrane and exposure of phosphatidyl serine as 
well as dissipation of the transmembrane mitochondrial potential (figure 1.2). 
Interestingly, apoptosis was observed exclusively in CD4+ but not in CD8+ T cells thus
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suggesting a significant role for this phenomenon in T helper cell depletion during HIV 
1 infection.
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Fig. 1.2: Schematic representation of the characteristics of the novel 
type of CD4 and CXCR4 mediated apoptosis. Triggering of the CD4 and
CXCR4 receptors by recombinant gpl20 crosslinked via anti-gpl20 
antibodies leads to a novel type of cell death. This involves condensation of 
the cytoplasm and chromatin, reduction of the mitochondrial transmembrane 
potential and exposure of phospatidyl serine on the plasma membrane (PS 
translocation). The death receptors CD95, TNF-Rl, TRAIL-Rl and TRAIL- 
R2 and components of the classical apoptotic signaling pathway , such as 
caspases and caspase substrates (PARP); do not play a role in this type of 
apoptosis. The death signal is not mediated by the CD4 associated tyrosine 
kinase p56‘"‘ or the CXCR4 associated GTPase G a.
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8 Signal transduction via the CD4 and CXCR4 receptors
8.1 CD4 signal transduction
Productive antigen receptor signaling in helper T cells requires coengagement of 
the CD4 coreceptor. CD4 binding to MHC class II molecules results in the stabilization 
of the TCR-MHC II interaction and activation of a signaling pathway initiated by the 
CD4-associated protein tyrosine kinase (PTK) Lck (Weiss and Littman, 1994). CD4 
engagement independently of the TCR has been shown to trigger the phosphorylation 
of a subset of the phosphoproteins triggered by the TCR, supporting the view that TCR 
and CD4 share a wide array of common signaling mediators. Thus CD4 triggering leads 
to phosphorylation of the PTKs Lck and Fyn, the adaptor molecule She, the MAP 
kinase Erk 2 and PI-3 kinase (Ulivieri et al., 1999). Coengagement of CD4 during TCR 
signaling is also necessary for the phosphorylation of the PTK ZAP-70 and the adaptor 
molecule c-Cbl (Murphy et al., 1998). Moreover CD4 coengagement has been shown to 
promote the phosphorylation of the membrane-associated adaptor LAT by ZAP-70, as 
LAT associates directly with CD4 and competes with Lck for the binding site (Bosselut 
et al., 1999).
Binding of HIV-1 envelope glycoprotein to CD4 has been shown to activate the 
MEK/ERK kinase pathway resulting in the expression of inflammatory genes (Popik et 
al., 1998). However whether CD4 signaling mediates HIV-induced apoptosis remains 
conroversial. Moutouh et al reported that initial signaling through CD4 was critical for 
HIV-1 induced apoptosis although this was independent of p56’‘'‘'. Other studies have 
indicated that signaling via CD4 may be dispensable for apoptosis induction (Guillerm 
et al., 1998; Jacotot et al., 1997). Moreover the recently described CD4 mediated novel 
type of apoptosis was also independent of p56 signaling.
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8.2 CXCR4 signal transduction
Signal transduction by chemokine receptors leads to the activation of G proteins 
and phospholipase C and the elevation of cytosolic free calcium (Baggiolini et al., 
1997). CXCR4-mediated responses are pertussis toxin (PTX) sensitive, indicating a role 
for Gitt in this signaling. Indeed, Q a  was shown to rapidly associate with CXCR4 after 
SDF-1 a  binding followed by receptor tyrosine phosphorylation via the JANUS kinase 
family members JAK2 and JAK3. Moreover SDF-1 a  induced the activation and 
association of the tyrosine phosphatase Shpl with CXCR4 in a G.a-dependent manner 
(Vila-Coro et al., 1999). Stimulation of CXCR4 by SDF-1 also results in increased 
phosphorylation of focal adhesion components, including the tyrosine kinase RAFTK 
(Pyk2), Crk and paxillin, activation of MAP kinases (Erkl and 2) and PI3 kinase (Ganju 
et al., 1998).
HIV-1 envelope glycoprotein binding to CXCR4 also leads to the activation of 
signal transduction pathways. Stimulation of CXCR4 by gpl20 induced Pyk2 
phosphorylation which was inhibitable by PTX, thus implicating Gi-linked pathways in 
this response (Davis et al., 1997). However, viral entry does not depend on Gi-coupled 
signaling and mutations that ablate signal transduction do not affect coreceptor activity 
(Cocchi et al., 1996; Farzan et al., 1997).
HIV-1 binding to CXCR4 in neuronal cells induced Gi-protein signaling which 
correlated with caspase activation and apoptosis (Zheng et al., 1999). However, CXCR4 
induced apoptosis in T lymphocytes was found to be independent of Gi-protein 
signaling and caspases (Bemdt et al., 1998; Blanco et al., 1999) and did not seem to 
involve phosphorylation of the cytoplasmic tail (Biard-Piechaczyk et al. 2000).
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9 Aims of project
Improvement of our understanding of the mechanisms of HIV-1 associated 
lymphocyte apoptosis, as well as the signaling cascades involved, may lead to 
therapeutic strategies aimed at intervening with the CD4+ T cell depletion in HIV-1 
infected individuals.
The work described in this thesis was undertaken in order to investigate the 
hypothesis that CD4 and CXCR4 mediated apoptosis may be a potential indirect 
mechanism of T-cell depletion during HIV-1 infection, thus contributing to HIV-1 
disease pathogenesis.
The relative contribution of the „classical“ or „novel“ apoptotic pathways engaged 
by these receptors, upon cell death induction, was investigated in the in vivo situation. 
Furthermore, factors determining sensitivity versus resistance to CD4 and CXCR4 
induced apoptosis were examined.
The work also aimed to investigate some of the signaling events involved in the 
„novel“ type of apoptosis triggered by the CD4 and CXCR4 receptors. For this purpose 
the work was particularly focused on the CD4 triggered apoptotic cascade.
Specific aims of the work were:
• CHAPTER 1: To investigate the sensitivity of PBLs from HIV-1 infected 
individuals to CD4 and CXCR4 mediated apoptosis in comparison to PBLs from 
healthy controls.
• CHAPTER 2: To investigate the apoptotic pathway engaged by the CD4 and 
CXCR4 receptors in PBLs from HIV-1 infected individuals.
• CHAPTER 3: To investigate whether PBLs from healthy individuals can be 
sensitized to undergo CD4 and CXCR4 mediated apoptosis via activation.
• CHAPTER 4: To gain some insight into the structural requirements of the 
CXCR4 and CD4 receptor for the propagation of the apoptotic signal.
• CHAPTER 5: To investigate the role of phosphorylation and recruitment of 
signaling molecules to the CD4 receptor complex during apoptosis.
• CHAPTER 6: To investigate the role of AIF and mitochondria during CD4 
mediated apoptosis.
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II Materials and Methods 
1 Materials
1.1 Chemicals
All chemicals were, unless otherwise stated, purchased from the following companies: 
Serva (Heidelberg, Germany), Fluka (Neu-Ulm, Germany), Sigma (Munich, Germany), 
Roth (Karlsruhe, Germany) and Merck (Darmstadt. Germany). Radioactive reagents 
were purchased from Amersham-Buchler (Braimschweig, Germany).
1.2 Buffers
DNA Sample Buffer (10 x): 50 % (v/v) Glycerol
0.42 % (w/v) Bromophenol blue
0.42 % (w/v) Xylene cyanole
Nicoletti Buffer: 0.1 % (w/v) Sodium citrate 
0.1% (w/v) Triton X-100 
50 pg/ml Propidium iodide
Cell Lysis Buffer 
(Eukaryotic cells): 150 mM NaCl 
30mMTris-HCl,pH = 7.5
1 mM 
10 % (w/v) 
1 % (w/v) 
0.5 pg/ml 
0.5 pg/ml 
0.5 pg/ml 
0.5 pg/ml
PMSF
Glycerol
Triton X-100
Antipain
Chymostatin A
Leupeptin
Pepstatin
Additionally, for phosphorylation studies the 
following were added :
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10 mM NaF
1 mM Na-orthovanadate
PBS: 137 mM 
8.1 mM 
2.7 mM 
1.5 mM
NaCl
Na2HP04
KCl
KH2PO4 pH = 7.4
TBE(lOx): 0.45 M Tris
0.45 M Boric acid
10 mM EDTA pH = 8.3
TE: 10 mM 
1 mM
Tris
EDTA pH = 7.5
Reducing sample-bufFer (5x): 50 % (v/v)
10 % (w/v) 
50 mM 
25 % (v/v) 
0.25 mg/ml
Glycerol
SDS
Tris, pH = 6.8 
P-Mercaptoethanol 
Bromophenol blue
Stacking gel (5 %): 24 mM 
5 % (w/v)
0.1 % (w/v) SDS 
0.1% (w/v) APS 
0.1 % (w/v) TEMED
Tris-HCl,pH = 6.8 
Acrylamide
Running gel: 37.5 mM Tris-HCl,pH = 8.8 
7.5-15 %(w/v) Acrylamide 
0.1 % (w/v) SDS 
0.03% (w/v) APS
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0.1 % (w/v) TEMED
Electrophoresis buffer 25 mM Tris-Base
(SDS-PAGE): 0.19 M Glycine
1 % (w/v) SDS
Fixing solution: 20 % (v/v) Methanol
10 % (v/v) Acetic acid
Transfer buffer: 25 mM Tris
(Western Blot) 0,19 M Glycine
20 % (v/v) Methanol
0.037 % (w/v) SDS
Nitrocellulose Wash Buffer: PBS wdth 0.1 % Tween-20
(TPBS)
1.3 Biological Material
1.3.1 Bacterial strains
E.coli TOP 10F% competent cells Invitrogen
E.coli XLl blue Stratagene
1.3.2 Cell lines
Cell line Origin
BJAB EBV-negative human Burkitt-
like lymphoblastoid line
H9 human T-cell-leukemia line
HPBALL human T-cell-leukemia line
JURKAT human T cell leukemia line
L929 murine fibrosarcoma line
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1.4 Media 
1.4.1 Cell culture media
RPMI 1640 Gibco BRL, Eggenstein
Iscove's Modified Dulbecco’s Medium Gibco BRL, Eggenstein
The media were supplemented with the following additives prior to use:
10% (v/v) FCS Gibco BRL, Eggenstein
10 mM HEPES Gibco BRL, Eggenstein
50 pg/ml Gentamycin Gibco BRL, Eggenstein
The following antibiotic was used for the selection of transfected eukaryotic cells: 
Geneticin (G418) Sigma, Deisenhofen
For cell labelling the following "deficient" medium was used:
r^ ^S 1 -Methionine/Cvsteine Cell Labelling: RPMI defficient medium (Gibco BRL, 
Eggenstein,Germany Cat.no.: 51871-010), supplemented with 10% dialysed FCS and 
all missing amino acids except cysteine and methionine.
1.4.2 Bacterial cell culture media
LB-Medium: 10 g/1 Casein Hydrolysate
5 g/1 Yeast Extract
10 g/1 NaCl
pH 7.2 adjusted with 1 N NaOH
LB-Agar: 1.5% Bacto-Agar in LB-Medium
LB-Agar selective plates: 1.5% Bacto-Agar in LB-Medium
Ampicillin 50-100 pg/ml 
or Kanamycin 25 pg/ml
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1.5 Antibodies 
1.5.1 Polyclonal Antibodies
Name Antigen Source, Reference
AIF rabbit anti-serum Apoptosis Inducing 
Factor
Susin et al., 1999
Lck (2102) rabbit IgG p56 lck Santa Cruz Biotechnology, 
Heidelberg, Germany
Goat anti-CD4 Human CD4 R & D systems
Sheep anti-Mouse IgG Mouse IgG Boehringer,Mannheim,
Germany
Goat anti-Mouse 
IgG(Fab')2  B-Phycoerythrin 
conjugated
Mouse IgG Dianova, Germany
Goat anti-IgGl, HRPO Mouse IgGl Southern Biotechnology, 
Birmingham, USA
Goat anti-IgG2a, HRPO Mouse IgG2a Southern Biotechnology, 
Birmingham, USA
Goat anti-IgG2b, HRPO Mouse IgG2b Southern Biotechnology, 
Birmingham, USA
Goat anti-Rabbit, HRPO Rabbit IgG Santa Cruz Biotechnology, 
Heidelberg, Germany
1.5.2 Monoclonal Antibodies
Name Antigen Source, Reference
12G5 (IgG2a) CXCR4 Pharmingen, San Diego, 
USA
12G5 (IgG2a) CXCR4 R & D systems
3G8 (IgGl) CD16 Immunotech
HP2/6 (IgG2b) CD4 Carrera etal., 1987
Leu3a (IgGl) CD4 Becton Dickinson
FITC-conjugated anti-CD4 CD4 Pharmingen, San Diego,
RPA-T4 (IgGl) USA
10H2 CXCR2 Genetech, CA,USA
anti-APO-1 
(IgG3 and IgGl)
CD95 Trauth et al., 1989
FITC-conjugated mouse Pharmingen, San Diego,
IgGl USA
C15 (IgG2b) Caspase-8 
p i8 subunit
Scaffidi et al., 1997
anti-FADD (IgGl) FADD Transduction
Laboratories, Lexington, 
USA
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CIIIO (IgGl) PARP Grube and Biirkle, 1992
anti-Cytochrome c (IgG2b) Cytochrome c Pharmingen, San Diego,
(AS 93-104) USA
anti-C0X4 (IgG2a) Cytochrome oxidase subunit Molecular Probes,
IV Oregon, USA
M-A251 (IgGl) CD25 Pharmingen, San Diego, 
USA
FN50 (IgGl) CD69 Pharmingen, San Diego, 
USA
HD37 (IgG2a) CD19 Pezzutto et al. 1987
0KT4 (IgG2b) CD4 Ortho-Clinical
Diagnostics,Germany
0KT8 (IgG2a) CD8 Ortho-Clinical
Diagnostics,Germany
UCHLl (IgG2a) CD45RO Pharmingen, San Diego, 
USA
HIlOO (IgG2b) CD45RA Pharmingen, San Diego, 
USA
H4149 Hsp60 Sigma-Aldrich,
Germany
PY99 (IgG2b) Phospho-Tyrosine Santa Cruz 
Biotechnology, 
Heidelberg, Germany
1.6 Molecular Biology Materials 
1.6.1 Vectors
Name Source
pcDNA3
pBluescript II SK+ 
pEGFP-Nl
Invitrogen
Stratagene
Clontech
1.6.2 Enzymes
Enzyme Source
Calf Intestinal Alkaline Phosphatase 
(CIAP)
Pfu DNA Polymerase
New England Biolabs, Schwalbach 
Promega, Mannheim
T4 Polynukleotide kinase 
T4 DNA Ligase________
MBI Fermentas 
MBI Fermentas
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All restriction endonucleases used were purchased from Boehringer Mannheim and 
MBI Fermentas.
1.6.3 Primers (Oligonucleotides)
Name Nucleotide Sequence (5'-3')
CXCR4 sense CATTCCCGCGGATGGAGGGGATC
AGTATATAC
CXCR4 antisense TGCTCTAGAGCTGGAGTGAAAAC
TTGAAG
CXCR4 Acyto sense ATACAAGCTTATGGAGGGGATC
AGTATATACACTTC
CXCR4 Acyto antisense ATACTCTAGATTAGAGTGCGTGC
TGGGCAGAGGTTTTAA
CXCR2 sense CATTCCCGCGGATGGAGAGTGAC
AGCTTTGAAG
CXCR2 antisense TGCTCTAGAGAGAGTAGTGGAAG
TGTGCCC
CXCR4 1 sense CCCAAGCTTATGGAGGGGATCAG
TATATAC
CXCR4 425 antisense GTGGCGTGGACGATGGCCAG
CXCR2 432 sense TTACCTGGCCATTGTCCATG
CXCR2 1080 antisense CCGGAATTCGAGAGTGGAAGTG
AGCCC
CXCR2 1 sense CCCAAGCTTATGGAAGATTTTAA
CATG
CXCR2 90 antisense GGGGACGGTAGTGCTGTAAC
CXCR4 82 sense GAAGAAAATGCTAATTTC
CXCR4 729 antisense GATGAGTGTGGTCAAGTTGAG
CXCR2 739 sense CACCGGGCCATGCGGGTC
1.7 Kits
BCA Protein Assay Kit 
Chemiluminescence Kit (ECL) 
Qiagen Plasmid Maxi Kit 
Qiagen Gel-Extraction Kit 
ApoAlert Cell Fractionation Kit
Pierce
Amersham-Buchler
Qiagen
Qiagen
Clontech
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1.8 Cytokine Receptor Constructs
CD95-R-Fc construct Dhein et.al, 1995
TNF-R2-Fc construct Peppel et.al., 1991
TRAIL-R2-FC construct Walczak et al., 1997
The Receptor-Fc constructs are chimaeras composed of a mouse IgGl Fc portion and
two extracellular domains from the respective receptors, which replace the
immunoglobulin antigen binding domains.
1.9 Molecular weight markers
1.9.1 Protein Markers
SeeBlue™ Plus2 Pre-Stained Standards Novex
Rainbow Marker AP-Biotech
1.9.2 DNA Markers
Ladder Mix (from 100 bp to lOkb) MBI Fermentas
MidRange PFG Marker I New England Biolabs
(Pulse Field Gel Electrophoresis)
1.10 Apparatus
Apparatus Source
Autoradiography cassette Suprema
Blotting apparatus Semi-Dry 20 x 25 cm CTI
Centrifuges: Biofuge A Heraeus
Omnifuge 2.0RS Heraeus
Centrifuge 5402 Eppendorf
Sorvall RC 3B PLUS, 5C DuPont
PLUS
Stericult Incubator Forma Scientific
Electrophoresis Power Supply Renner
Consort 865
Electroporation apparatus Gene Puiser II Biorad
Film developing apparatus Curix Agfa-Gevaert
160
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Flow cytometer FACScan Becton Dickinson
Gel elecrophoresis chambers: Horizon 11.14 Gibco BRL
SDS-PAGE CTI
Bio-RadCHEF-DRII 
( nucleic acid PAGE)
Biorad
Minigel chamber Biorad
Microscopes: Light microscope ID 02 Zeiss
Phase contrast microscope 
Labovert FS
Leitz
Confocal microscope Olympus
PCR maschine Gene Amp 9700 Perkin Elmer
Photo unit UV-Flachenstrahler Konrad Benda
Kamera RAl Kaiser
Video Graphic Printer UP- 
860 CE
Sony
Photometer U-1100 Hitachi
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Methods
2.1 Cell culture methods
2.1.1 Eukaryotic cell culture
All cell culture work was performed under sterile conditions in order to avoid 
contamination with bacteria, yeast or fungi. The cell culture material used was gamma- 
irradiated and all solutions and media were sterile filtered.
Suspension cells were kept in a minimum density of 1x10^ cells/ml and a maximum of 
1x10^ cells/ml. Various cell types were cultured in the following media:
RPMI 1640 medium: BJAB, HPBALL, H9, primary human lymphocytes 
Iscove's ModifiedDulbecco's Medium:Jmkat
BJAB tranfected cells were cultured in RPMI 1640 medium containing 4 mg/ml 
Geneticin.
2.1.2 Cell counts determination
Cell counts were performed by using a Neubauer cell count chamber and Trypan 
blue dye exclusion. A fresh cell culture aliquot was diluted 1:1 with 0,1% Trypan blue 
solution in order to discriminate between live and dead cells. Trypan blue binds to 
cytoplasmic protein structures but can only enter cells with leaky plasma membranes. 
These cells represent the dead cells. The trypan blue negative cells were counted in 2 
big quadrats of the Neubauer chamber and the cell count (live cells /ml culture) was 
determined according to the following formula:
Count 2x16 squares=N
(N X dilution factor) / (2 x 100)= ....xlO^ live cells/ml culture
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2.1.3 Freezing and thawing cells 
Freezing
5x10^ to 1x10^ cells were centrifuged (10 min, 1200 rpm, 4°C) and the pellet 
was resuspended in 1 ml chilled freezing medium (90%FCS, 10% DMSO). The cells 
were quickly frozen at -80°C and kept for 48-72 h before being transferred to a liquid 
Nitrogen tank.
Due to its high Dielectric constant Dimethyl-sulfoxide (DMSO) prevents the 
formation of destructive ice crystals at low temperatures while above and in the range 
of the freezing point it allows solubilisation of cell membranes. In order to minimize the 
toxic effects of DMSO, the freezing solution was kept cold during the procedure which 
was carried out in the fastest time frame possible.
Thawing
Liquid nitrogen frozen cells were defrosted in a 37°C waterbath. In order to 
ensure reaching a temperature close to the freezing point, which protects the cells from 
the toxic effects of RT freezing medium, resting ice particles should be seen in the cell 
solution. The cells were then tranferred to a tube containing 10 ml of warm medium and 
centrifuged at 1500 rpm for 5 min. The washing step was repeated in order to ensure 
complete removal of the freezing medium. The cells were then transferred to a 25 cm^ 
cell culture flask at a density of 5x10^ cells/ml and kept in an incubator at 37°C, 95% 
humidity and 5% CO2 content.
2.2 Immunological Methods
2.2.1 Human Peripheral Blood Lymphocyte Purification
Human peripheral blood lymphocytes (PBLs) were isolated by Ficoll-Hypaque 
density centrifugation. Briefly, blood was obtained from adult volunteers by intravenous 
puncture into heparinised syringes (5000 units Heparin sodium salt/ml of blood). The 
blood was diluted 1:1 with 37°C RPMI medium, slowly layered onto 37°C Ficoll 
(Biochrom, Berlin) and centrifuged (2420 rpm, 20 min, 20°C). The mononuclear cell
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layer was gently aspirated and washed twice with 3 volumes PBS at 1200 rpm for 10 
min at 20°C (Omnifuge 2.0RS). The cells were then resuspended in complete RPMI 
medium. Monocytes and macrophages were depleted by adherence to cell culture flasks 
for 2 h at 37°C. The non-adherent lymphocytes were recovered and counted (see
II.2.1.2). PBL numbers typically recovered using this method ranged from 1-2x10^ 
cells /ml of blood.
2.2.2 Isolation of PBL subpopulations
PBL subpopulations were isolated using an immunomagnetic cell separation 
method. This method is based on antibody mediated coupling of cells to "magnetic 
beads": uniform, superparamagnetic monodisperse particles with identical physical and 
chemical composition. The magnetic beads used were coupled to anti-Mouse-IgG and 
therefore bound to cells bearing mouse antibodies against surface markers.
Briefly, 5x10^ PBL were centrifuged (1200 rpm, 10 min) and resuspended in 
400 fxl culture medium. 25 pg/ml of a monoclonal mouse antibody against the antigen 
of interest (i.e CD4, CDS, CD45RA, CD45RO) were added and the cells were incubated 
on a rotator for 20 min at 4°C. The cells were washed once to remove unbound antibody 
and the cell pellet was resuspended in 400 pi beads-suspension (8x10^ magnetic beads). 
The cells were further incubated as before and then transferred to a magnetic apparatus 
for 2 min at RT. The magnetic beads vrith the bound cells were directed towards the 
apparatus while the "negatively selected" unbound cells remained in suspension. The 
cells were then gently recovered into a new tube washed and counted. This method of 
purification typically generated > 90% pure populations.
The "negative selection" of PBL subpopulations here described avoids unwanted 
activation of the cell population of interest via antibody binding.
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2.2.3 Immunofluorescence staining
2.2.3.1 Immunofluorescence staining of surface molecules
Surface antigen expression analysis was performed by using 3-5x10^ cells of 
interest. The cells were centrifuged (5 min, 1500 rpm) and the pellet was resuspended 
in 100 pi PBS. Ipg of relevant monoclonal primary antibody was added and incubated 
for 15-60 min at 4°C in order to prevent internalisation of the surface molecules. 
Unbound antibody was washed away by adding 2 ml of medium and centrifugation (10 
min, 1200 rpm). The cells were then resuspended in 50 pi medium containing lOpg/ml 
fruorescent dye-conjugated secondary antibody and incubated at 4°C for 15 min. The 
cells were washed twice with PBS and resuspended in 200 pi fixing solution (PBS/1 % 
formaldehyde). Thus the stained samples could be kept for several weeks in the dark, at 
4°C.
Immunofluorescent cells were analysed in a FACScan flow cytometer (Becton 
Dickinson, CA, USA). The cells were taken up via a capillary and excited by an Argon 
laser with a wavelength of 1=488 nm. The wavelength of the light emitted by the 
excited electrons was dependent on the fluorescent dye used. The light was then 
collected and redirected to detectors via different mirrors and filters. These detectors 
provided information concerning the size ("forward scatter", FSC), granularity ("side 
scatter", SSC) and fluorescence ("fluorescence detector", FL) of the cells analysed.
2.2.3.2 Intracellular Immunofluorescence staining
In order to analyse the expression of intracellular proteins the cells were fixed 
and permeabilised prior to the addition of the antibodies. Briefly, 5x10^ cells of interest 
were washed once with PBS (1200 rpm, 5 min). The cells were then resuspended in 500 
pi fixing solution (Paraformaldehyde 4%, Picric acid 0,19% in PBS) and incubated for 
30-60 min at RT. The cells were subsequently washed three times with PBS (1200 rpm, 
5 min) and permeabilised with PBS/0,1% SDS for 10 min at RT. The three washing 
steps were repeated and potential unspecific binding of the antibodies was blocked by a 
20 min incubation with PBS/10% FCS. The cells were washed once with PBS and 
incubated with the relevant primary antibody for 60 min at RT. The cells were washed
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three times with PBS and incubated with a fluorescent dye-conjugated secondary 
antibody for 30 min in the dark. The cells were again washed three times with PBS and 
pipetted onto poly-L-lysine slides, a cover glass was placed on the slide and the samles 
were analysed using Confocal Microscopy.
Alternatively, for certain applications the cells were transferred to poly-L-lysine 
slides after fixation and washing. As all cells used were in suspension this was achieved 
by using cytospins. Briefly, the cells were resuspended in 350 pi PBS and transferred to 
slides via centrifugation for 5 min at 500 rpm. Cell permeabilisation and staining was 
then performed as described above.
2.3 Apoptosis assays
2.3.1. Analysis of morphological changes ( FSC/SSC analysis)
During apoptotic cell death coordinated morphological changes occur in the 
nucleus, cytoplasm and at the cell surface. Characteristic changes include loss of cell 
volume due to loss of water and ions with consequent compaction of the organelles and 
an increase in cell density. These specific structural changes can be detected via Flow 
cytometry, thus allowing the differentiation between live, apoptotic and necrotic cells. 
Apoptotic cells show reduced forward scatter (FCS) corresponding to reduced cell size 
and increased side scatter (SSC) corresponding to increased granularity. The amount of 
apoptotic cells within a cell population was determined using a FACScan. The FSC- 
signal was plotted against the SSC-signal (FSC/SSC) and the number of cells within 
defined regions , characteristic for certain cell populations, was evaluated.
2.3.2 Propidium Iodide exclusion
The red fluorescence dye Propidium (used as a Propidium Iodide-salt PI) binds 
unspecifically to dead cells. The propidium cation can enter dead cells which have lost 
plasma membrane integritiy while it is excluded from live cells with intact plasma
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membranes (Tanke et.al., 1982). All dead cells (apoptotic and necrotic) are stained and 
can be analysed by Flow Cytometry.
Briefly, 1x10^ cells were resuspended in 100 pi medium and incubated in a 96- 
well plate in the absence or presence of a cytotoxic agent. In order to determine cell 
death, the cells were transferred to a 1 ml FACS tube and 100 pi of PI- 
solution(PBS/5pg/ml PI) were added shortly before measurement in the Flow 
Cytometer. The samples were kept at 4°C prior to measurement. The light emmitted by 
the Argon laser excited PI has a wavelength of 1=650 nm and can be measured via the 
FL2 and FL3 detectors.
2.3.3 Calculation of specific apoptosis
In several experiments the amounts of dead cells were presented as "% specific 
cell death".
Percentage of specific cell death was calculated according to the formula: 
specific cell death (%) =100 * [X - S]/[100 - S].
where X = mean of 3 measurements of experimental cell death
S = mean of 3 measurements of spontaneous cell death
2.3.4 Nicoletti assay
The Nicoletti assay (Nicoletti et.al., 1991) is a flow cytometric method for 
measuring the percentage of apoptotic nuclei. These can be discriminated firom nuclei of 
living cells due to their hypodiploid DNA content.
Briefly, 5x10^ cells were centrifuged and gently resuspended in 250 pi hypotonic 
fluorochrome solution (PI 50 pg/ml in 0,1% sodium citrate plus 0,1% Triton X-100). 
The cells were incubated at 4°C in the dark overnight for lysis to occur. The fluorescent 
dye could then enter nuclei and intercalate into the DNA thus allowing the measurement 
of the stained nuclear DNA. Apoptotic nuclei could be detected by flow cytometry via
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the FL2 detector as a hypodiploid DNA peak in contrast to normal nuclei with a diploid 
DNA content.
DNA fragmentation into oligonucleosomal subunits and reduction of nuclear DNA 
content are hallmarks of classical apoptosis. The Nicoletti assay therefore allows the 
identification of cells undergoing classical apoptosis and discrimination from necrotic 
cells.
2.3.5 MTT assay
Determination of cell death via the MTT assay is based on the conversion of the 
yellow tétrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) into dark blue formazan crystals. This conversion reflects the activity of the 
mitochondrial respiratoiy chain (Mosmann, 1983). Therefore, this assay detects living 
cells since dead cells cannot carry out the reaction.
10"^  cells were seeded in triplicate in flat-bottom 96-well plates and incubated 
with the appropriate stimuli. 25 pi MTT solution (PBS/ 5 mg/ml MTT) were added and 
incubated for 4 h. The reaction was terminated by the addition of 100 pi stop solution 
(isopropanol/ 5% formic acid) and the formazan crystals were dissolved under vigorous 
shaking. The absorption of the yellow tétrazolium salt was determined at h= 550 nm in 
an Elisa reader. Specific cell death was calculated according to the following folmula: 
specific cell death (%)= 1 -  (E/T)
T= A550 nm in the absence of cytotoxic stimulus 
E= A550 nm of unknown sample
2.3.6 Large-scale DNA fragmentation assay
Large-scale DNA fragmentation, i.e chromatin digestion into fragments of 
approximately 50 Kbp (Susin et.al., 1999) represents an early step of the apoptotic 
process. These high molecular weight DNA fragments can be visualised by Pulse-field 
gel electrophoresis (Schwartz and Cantor, 1984).
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For the demonstration of large-scale DNA fragmentation 1x10^ cells of interest 
were washed once with PBS. The dried pellets were then incorporated into agarose 
plugs to avoid shearing of DNA during extraction. The pellets were resuspended in 
molten, low-melting-temperature agarose and solidified in blocks whose size matched 
the thickness of the loading slot of the gel. The cells were digested twice with 1 mg/ml 
proteinase K in NDS buffer (0,5 M EDTA, 10 mg/ml lauroyl sarcosine) for 12h at 50°C. 
The agarose plugs were then washed in 0,5xTBE and loaded onto a 1% agarose gel 
followed by elecrophoresis in 0,5xTBE buffer for 24 h at 200 V with a pulse wave of 60 
s and 120° angle (Bio-RadCHEF-DR II).
2.3.7 Assessment of Mitochondrial Transmembrane Potential (A'Pm)
Apoptotic cells exhibit a reduction in mitochondrial transmembrane potential 
(A'Pm) of the inner mitochondrial membrane which precedes other apoptosis associated 
changes like DNA fragmentation chromatin condensation and membrane disruption 
(Zanzami et.al., 1995). AYm can be evaluated by using the fluorochrome 3,3'- 
dihexyloxacarbocyanine iodide (DiOC6(3)) (Molecular Probes, Inc.). DiOC6(3) is a 
cationic dye which binds specifically to mitochondrial membranes with intact 
transmembrane potential thus giving a high fluorescence signal. Upon disruption of the 
transmembrane potential however it no longer accumulates in the mitochondria 
resulting in a reduced fluorescence signal.
DiOC6(3) was kept as a stock solution (80 mM in DMSO) at RT and used in a 
final concentration of 40 nM in PBS. 1x10^ cells of interest were centrifuged, washed 
once with PBS and resuspended in 100 pi PBS/ DiOC6(3). Following incubation for 15 
min at 37°C the cells were washed once with chilled PBS and resuspended in 100 pi 
PBS. The samples were kept on ice until they were measured by flow cytometry (501 
nm, FL-1 detector).
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2.3.8 Cytochrome C release assay
Apoptosis is accompanied by signs of mitochondrial membrane 
permeabilization (MMP), including loss of the inner mitochondrial transmembrane 
potential (AWm) and the release of soluble intermembrane proteins via the outer 
mitochondrial membrane.
MMP results in the tranlocation of cytohrome c (Cyt-c) from the mitochondrial 
intermembrane space to the cytosol. Thus, localisation of cytochrome c serves as a 
marker for mitochondrial involvement in apoptosis.
In order to determine the localisation of cytochrome c the mitochondrial fraction 
was separated from the cytosolic fraction of apoptotic and nonapoptotic cells using the 
ApoAlert cell fractionation kit (Clontech) according to the manufacturer's protocol. 
Subsequently cytochrome c localisation was determined in the different fractions by 
western blot analysis
2.3.9 Induction of cell death via aCD4 and aCXCR4
For the induction of apoptosis via CD4 and CXCR4 10  ^cells were incubated in 
60pl of culture medium in the presence or absence of lOpg/ml mAbs against CD4 or 
CXCR4 or both, for 30 min, at 37°C. The cells were subsequently transferred to a 96 
well microtiter plate previously coated with 50pg/ml sheep-anti mouse Ig.
For the investigation of the apoptosis inhibition (chapter 2) PBLs were incubated 
as before and either CD95- Fc (50 pg/ml), or TNF-R2-Fc (30pg/ml), or TRAIL-R2-Fc 
(30fig/ml), or the caspase inhibitor BOC-Asp(OMe)-fmk ( 50pM) were included in the 
assay. The samples were preincubated for 40 min with the inhibitors and the 
aCD4/aCXCR4 mAbs before being transferred to sheep anti-mouse Ig coated plates. 
Apoptosis was assayed after the appropriate incubation time using one of the methods 
described above.
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2.4 Molecular Biology Methods
2.4.1 Preparation of Plasmid DNA
2.4.1.1 Mini Preparation
2 ml of a bacterial cell culture in the exponential growth phase were centrifuged 
(2 min, 5000 rpm, 20°C) and the pellet was resuspended in 500 pi STET-Buffer (8% 
Sucrose, 0,5% Triton X-100, 50mM EDTA, lOmM Tris/HCl, pH 8). The bacterial cells 
were lysed by addition of 50pl lysozyme solution (50mg/ml) for 3 min at RT. They 
were then icubated for 90 sec at 95°C, in order to induce protein dénaturation, and 
centrifuged (5 min, 13.000 rpm) in order to exclude cell debris. The supernatant was 
tranferred into a new tube and the plasmid DNA was precipitated after addition of 0,5 
ml isopropanol and 50 pi ammonium acetate (8M) and immediate centrifugation (5 min, 
13000 rpm). The pellet was then washed with 70% ethanol, air-dried for 10 min and 
dissolved in 30 pi sterile deionized H2O.
2.4.1.2 Maxi Preparation
For the preparation of large amounts of plasmid DNA the Qiagen Plasmid Maxi 
Kit was used according to the manufacturer’s protocol.
2.4.2 Polymerase Chain Reaction (PCR)
The polymerase chain reaction is used to amplify a segment of DNA that lies 
between two regions of known sequence. Two oligonucleotides are used as primers for 
a series of synthetic reactions catalyzed by a DNA polymerase. The DNA to be 
amplified (template DNA) is first denatured by heating in the presence of the two 
nucleotides and four dNTPs. The reaction mixture is then cooled to a temperature that 
allows the oligonucleotide primers to anneal to their target sequences, after which the 
annealed primers are extended with DNA polymerase. The cycle of dénaturation, 
annealing, and DNA synthesis is then repeated many times. As the products of one 
round of amplification serve as templates for the next, each successive cycle doubles the 
amount of the desired DNA product.
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Briefly the following standard protocol was used:
5 pi lOx PCR-Buffer
I p l dNTPs (10 mM dATP, dGTP, dCTP, dTTP)
Ip l Primer 1(100 pmol)
I p l Primer 2(100 pmol)
1-50 ng Template DNA
I p l Pfu DNA-Polymerase
in 50 pi reaction volume (adjusted by addition of H2O)
The reaction was overlayed with 50 pi mineral oil and run with the following 
temperature profile:
Start Initial 4 min at 94°C
Dénaturation
25-35 Dénaturation 1 min at 94°C
Cycles Annealing 1 min at 56°C
Elongation 1 min at 72°C
Termination 5 min at 72°C
The annealing temperature for specific sets of primers was calculated as follows: 
Temp= 2x(A or T) + 4x (G or C) -  4°C
2.4.3 DNA restriction cleavage
The DNA restriction cleavage reactions were carried out by using 1-2 pg of 
plasmid DNA, prepared via a mini or maxi plasmid preparation. 2 U of an appropriate 
restriction endonuclease were added and the reaction was performed in the presence of 
an enzyme specific reaction buffer provided by the manufacturer. The reaction was
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incubated for at least 1 h at 37°C. The resulting restriction fragments were analysed by 
agarose gel electrophoresis.
2.4.4 Agarose Gel Electrophoresis
Following digestion of DNA with restriction enzymes, the DNA fragments can 
be separated and identified via electrophoresis through an agarose gel.
Briefly, IxTBE buffer was used for the preparation of the gel and as running buffer. 
Depending on the size of the DNA fragments to be resolved 0,7-2 % agarose gels were 
used. Fragments between 0.8 and 12 Kb were analysed in a 0.8 % agarose gel while 
fragments between 0.5 and 2 Kb in a 2% agarose gel. After the addition of DNA 
sample buffer the samples were loaded on the gel and run for 60-120 min at 80 V. A 
DNA molecular weight marker, containing a mixture of fragments of known sizes, was 
also loaded on the gel.
Following electrophoresis the gel was incubated for 15 min in TBE/0.5 pg/ml ethidium 
bromide and washed 3 times for 5 min with H2O.
The fluorescent dye ethidium bromide intercalates unspecifically into double­
stranded DNA molecules thus allowing the detection of the DNA fragments by direct 
examination of the gel in ultraviolet light.
2.4.5 DNA extraction from Agarose Gels
The extraction of DNA fragments for agarose gels was performed by using the 
Qiagen Gel-Extraction kit according to the manufacturer’s protocol.
2.4.6 Vector dephosphorylation
Restriction enzyme digested plasmid DNA should be dephosphoiylated prior to 
use in a ligation reaction. Dephosphorylation prevents recircularization of the 
linearized vector without insertion of the foreign DNA.
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Briefly, 10 U of Calf Intestinal Alkaline Phosphatase (CLAP) were added to a 
restriction reaction followed by a further incubation for 45-60 min at 37°C.
2.4.7 DNA Ligation
Ligation of fragments of foreign DNA of interest to plasmid vectors was 
performed by using a 1:3 concentration ratio of vector to insert. The ligation reaction 
had the following composition:
15 pi Vector +Insert (adjusted by addition of H2O) 
2pll0m M L i[A T P]
2pl lOx Ligation buffer 
Ipl T4 DNA Ligase
The ligation reaction was incubated either for 3- 4 h at RT or overnight at 16°C.
2.4.8 Tranformation
Amplification of plasmid DNA is achieved via transformation in bacteria. 
Competent E.coli XLl and TOP 10 F bacterial strains were used for transformation.
Briefly, 50 pi of competent bacteria were thawed on ice. 1-5 pi DNA (100-200 
ng) were added, followed by a 30 min incubation on ice. The cells were then heated at 
42 °C for 95 sec and then chilled on ice for 2 min, thus inducing permeabilization of the 
bacterial cell wall and uptake of foreign DNA molecules. 900 pi of antibiotic free LB 
medium were added and the cells were incubated for 30-45 min at 37°C in order to 
induce antibiotic resistance. The cells were then plated onto antibiotic containing LB- 
agar and incubated overnight at 37°C to allow selection of bacteria carrying the 
plasmid of interest. Several bacterial colonies were subsequently picked and the plasmid 
DNA was amplified and purified via a Mini Preparation (see II.2.4.1). A restriction 
analysis was then performed and positive clones, containing the plasmid of interest, 
were used to produce larger amounts of DNA via a Maxi Preparation (see II.2.4.2).
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2.4.9 Stable transfection of eukaryotic cells via electroporation
Expression of proteins of interest in eukaryotic cells was achieved via 
transfection of the respective plasmid DNA. The DNA was transfected to the cells via 
electroporation (Neumann et. al., 1982). Briefly, 5x10^ cells were centrifuged (10 min, 
1200 rpm), resuspended in 400 pi culture medium and transferred to an electroporation 
cuvette. 10-30 pg of plasmid DNA were added, gently mixed and the cells were 
electroporated at 960 pF and 220 V. The cells were immediately transferred to a 6-well 
plate and resuspended in 6 ml warm culture medium. Following a 48 h incubation the 
cells were counted, centrifuged and resuspended in selection culture medium (see 
2.1.1). The cells were then transferred to 96 well plates at a density ranging from 10  ^to 
10"^  cells per well. 2-3 weeks later single cell colonies were seen in the microtiter plates. 
These were tested for the expression of the protein of interest via immunofluorescence 
staining (see 2.2.3.1).
2.5 Biochemical Methods
2.5.1 Preparation of eukaryotic cell lysates
1x10^ cells per sample were incubated with the appropriate stimuli, centrifuged 
in a 50 ml tube (5 min, 1200 rpm , RT) and washed once with 50 ml PBS. The cells 
were resuspended in 1 ml PBS transferred to an eppendorf tube and centrifuged (5 min, 
4000 rpm, 4°C). The supernatant was discarded, the cell pellet was resuspended in lysis 
buffer (1ml lysis buffer/ 10  ^ cells) and incubated for 20 min at 4°C. Following 
centrifugation (15 min, 13000 rpm, 4°C) the supenatant was transferred to a new tube 
and the protein concentration was determined. 6 pi reducing sample buffer were added 
and the samples were incubated for 3 min at 95°C. The samples were then analysed by 
polyacrylamide gel electrophoresis.
2.5.2 Protein Concentration Assay
The determination of protein concentration was performed by using the BCA 
protein assay.
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Bicinchoninic acid (BCA) builds a highly specific violet complex with Cu^  ^
which is formed when Cu"^  ^ is reduced by protein in an alkaline environment. This 
water-soluble complex exhibits a strong absorbance at 562 nm that is linear with 
increasing protein concentrations. The advantage of this method is that it is compatible 
with detergents thus allowing the determination of protein concentration of cell lysates.
Briefly, 1 ml BCA reagent (1:50 CuS0 4 :BCA) was added to 50 pi protein 
solution (5 pi lysate + 45 pi PBS). The reaction was incubated for 30 min at 37°C and 
then measured in a spectrophotometer at 1=562 nm.
The protein concentration of the sample is determined by comparison to a 
standard concentration versus absorbance curve prepared by using a dilution series of 
BSAinPBS.
2.5.3 Sodium dodecyl sulphate gel electrophoresis (SDS-PAGE)
The denaturing polyacrylamide gel electrophoresis was used for the separation 
of proteins according to their molecular weight. The method used was the discontinuous 
gel electrophoresis originally described by Laemmli, 1970.
7,5-15 % acrylamide running gels and 5 % acrylamide stacking gels were used. The 
gels had the following dimensions:
Stacking gel: 233 mm x 12 - 27 mm x 1.5 mm 
Running gel: 233 mm x 203 mm x 1.5 mm
The gel composition is shown in II. 1.2. Polymerization of the gels was initiated 
by the addition of 0.1 % (v/v) TEMED and the polymerising solution was immediately 
used. The running gel was overlayed with isopropanol and left to polymerize for 30 
min. The isopropanol was then washed away with water and the remaining liquid was 
removed with filter paper. The gel was then cast with the stacking gel which was left to 
polymerize for 10 min. The gel was then loaded and run at 80-200 V for 8-18 h.
Materials and Methods 47
2.5.4 labelling of eukaryotic cells
For the radioactive labelling of newlly synthesized proteins cells, in the 
exponential growth phase, were incubated in deficient RPMI medium (see II. 1.4.1) for 
1 h at 37°C. The medium was subsequently supplemented with labelled cysteine and 
methionine. 1 mCi ^^S-cysteine/methionine (Pro Mix, Amersham) per 3x10^  cells was 
used. The cells were incubated for 24 h at 37°C and were then washed once in PBS.
The samples were either stimulated with appropriate antibodies or left untreated and 
were analysed by one dimensional gel electrophoresis (see II.2.5.3). Following 
electrophoresis the gel was dried for 2 h at 80°C and was placed under an X-ray 
sensitive film (X- OMAT AR, Kodak).
2.5.5 Immunoprécipitation
1x10^ unstimulated or stimulated cells were lysed as described in II 2.5.1 . 
Samples were clarified by centrifugation at 14000 rpm for 15 min at 4°C. Insoluble 
nuclei formed a pellet which was avoided as the supernatant was removed. 20 pi of 
mouse IgG coupled protein A-sepharose beads were added to the clarified supernatants 
and incubated for 1 h at 4°C on a tumbler in order to reduce unspecific binding of 
proteins to the immunoprecipitating antibody (control immunoprécipitation).
The samples were centrifuged and the precleared lysates were incubated with 20 
pi protein-G-sepharose beads and appropriate antibodies against the antigens of interest. 
The samples were incubated for 1-4 h at 4°C on a tumbler and then washed 5 times with 
1 ml lysis buffer (1 min, 6000 rpm). The beads were then dried using a Hamilton 
syringe and 40 pi reducing sample buffer were added prior to boiling for 5 min at 95°C. 
The samples were then analysed by gel electrophoresis.
2.5.6 Western Blot
Proteins were transferred from polyacrylamide gels to nitrocellulose membranes 
by electroblotting (Towbin et. al., 1979).
Semi-dry transfer:
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All elements used were presoaked in transfer buffer (see II. 1.2). The gel and 
membrane (Hybond-ECL membrane C, Amersham-Buchler, Braunschweig) were 
placed between sheets of absorbant paper (4 on each side). The graphite electrodes of 
the blotting chamber were also humidified with transfer buffer and the blot was run at 
0.8 mA/cm^ for 90 min at RT.
Wet transfer:
The gel and membrane were placed between sheets of absorbant paper (3 on 
each side) and were immersed in the transfer buffer (25 mM Tris, 192 mM glycine, 20% 
methanol) in a tank blot. The blot was run at 500 mA for 90 min at 4°C.
Following transfer, non specific binding sites on the nitrocellulose membrane 
were blocked by incubation with 5% (w/v) milk powder or 5% (w/v) BSA in TPBS, for 
1 h at RT. Membranes were washed 3 times for 10 min with TPBS. Appropriate 
primary antibodies were diluted in TPBS and incubated for 1 h at RT or overnight at 
4°C, with constant shaking. Membranes were washed 3 times for 10 min with TPBS. 
Detection horseradish peroxidase (HRP) conjugated antibodies were diluted 1:20 000 in 
TPBS and incubated with the membranes for 45 min with gentle shaking. Membranes 
were washed a further 3 times with TPBS.
Detection of proteins was achieved by a 2 minute incubation with the ECL 
reagent (Rennaissance-Kit, NEN, Bad Homburg v.d.H). HRP catalyses the oxidation of 
the ECL substrate luminol in the presence of hydrogen peroxide, which leads to the 
emission of light. Excess ECL reagent was removed and the membrane was placed 
under an X-ray sensitive film (X- OMAT AR, Kodak). Films were processed through an 
X-ray developer at various exposure time points.
Blot stripping
Antibody complexes can be removed from nitrocellulose membranes which can 
then be reprobed for different proteins. Membranes were incubated in "Stripping buffer" 
(62.5 mM TrisHCl pH=8. 2% SDS, 100 mM B-Mercaptoethanol) for 30 min, at 56°C.
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Membranes were washed 6 times with TPBS for 10 min at RT. The membranes were 
then blocked and incubated with appropriate antibodies as described above.
2.6 Statistical methods
The Wilcoxon Rank-sum test (Lehmann, 1975) was used for the comparison of 
distributions of two independent samples. The shift in location was estimated by the 
Hodges-Lehmann estimate together with the 95% confidence interval for the shift 
parameter. If more than two groups had to be compared the Kruskall-Wallis test 
(Lehmann, 1975) was applied.
A outpoint analysis of specific apoptosis was performed using a maximally 
selected test statistic according to the test procedure by Miller & Siegmund (1982). 
Possible cut point estimates were tested in the midth 80% of the specific apoptosis 
values obtained with the different stimuli. The test was used to calculate the statistic 
and P value for each specific apoptosis value considered. The corrected P value was 
then calculated according to Miller & Siegmund for the maximum of the statistic. 
Cut point estimates with corrected P values<0.05 were considered statistically 
significant. 95% bootstrap confidence sets were computed according to Diimbgen 
(1991). To analyze the effect of therapy on the specific apoptosis a linear regression 
analysis was performed.
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III RESULTS
1 aCD4, aCXCR4 induced apoptosis in PBLs from HIV-1 infected 
individuals.
Previous studies have shown that the HIV-1 surface glycoprotein gpl20 induces 
apoptosis in T cells via CD4 and recently also via CXCR4 (Bemdt et al., 1998). In these 
experiments it was shown that both receptors can mediate a “novel” type of caspase 
independent apoptosis. The experiments presented here were designed in order to 
investigate whether this novel aCD4 and aCXCR4 induced apoptosis is relevant to the 
pathophysiology of HIV-1 infection. Susceptibility of PBLs from HIV-1 infected 
individuals to CD4/CXCR4 mediated apoptosis was assessed in comparison to that of 
PBLs from healthy individuals. Subsequently the features of aCD4/aCXCR4 induced 
apoptosis in HIV-1 infected PBLs were investigated.
1.1 Patient characterisation
The HIV-1 positive individuals who took part in this study were recruited from 
the Department of Internal Medicine I, Mannheim Medical School, University of 
Heidelberg and from the private practice of Drs. Schuster/Brust in Mannheim. The 
study was approved by the Ethics Committee II of the University of Heidelberg and 
performed in accord with the Declaration of Helsinki. An informed consent was 
obtained from all participants. All HIV-1 infected individuals were classified according 
to the GDC, 1993, and were older than 18. The clinical and immunological 
characteristics of the participants are shown in Table III.l. Exclusion criteria were 
endocrinological diseases, liver cirrhosis, serum creatinine higher than 1.5 mg/dl, 
cardiorespiratory insufficiency, alcohol or drug abuse. As a control group, healthy blood 
donors were recruited from the staff of the collaborating institutions.
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HIV-1 HIV-1^
No. of patients 78 202
Age (years)' 31.2 ±9.24 39.3 ± 9.9
Sex (F/M) 32/46 65/137
Viral load (log copies/ml) ' ND 4.6 ±5.15
CD4" cells (cells/pl)' ND 439.3 ± 247.5
CD8" cells (cells/pl)' ND 1017.1 ±595.9
CD4VCD8" ratio' ND 0.42 ± 0.32
Treatment ^
■
Naive (n=52)
ART, double (n=31) 
ART, triple (n=49) 
HAART, triple+PI (n=70)
Stage (CDC 1993)'
-
A1/A2 (n=7/3) 
B1/B2/B3 (n=41/l 14/18) 
C1/C2/C3 (n=l/l/17)
Table III.l: Patient characteristics. ' numbers are mean ± SD ^ART: 
antiretroviral therapy; double, triple: combinations of two or three nucleoside 
or non-nucleoside analogues, HAART: highly active ART, PI: protease 
inhibitor  ^ CDC centres of disease control, classification of 1993 in n=28 
patients the viral load was below 50 copies/mL (detection limit), bDNA Test 
(Chiron company)
1.2 Increased susceptibility of PBLs from HIV-1 infected individuals to aCD4 and
aCXCR4 induced apoptosis
The sensitivity of PBLs from HIV-1 infected individuals to aCD4 and aCXCR4 
induced apoptosis in comparison to PBLs from healthy controls was examined. In order 
to mimick gpl20 binding and to activate both receptors individually mAbs against CD4 
(HP2/6) or CXCR4 (12G5) were used. The mAbs used interfere with binding of gpl20 
as determined by surface staining or inhibit HIV-1 infection, respectively. Moreover, in 
order to evaluate whether stimulation via both CD4 and CXCR4 shows an additive 
effect, PBLs were also stimulated with both antibodies simultaneously.
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Fig. III.l: CD4 and CXCR4 mediate apoptosis in PBLs from HIV-1 
infected individuals. FSC/SSC analysis of apoptosis in PBLs from a 
representative HIV-1 negative (left panels) and a HIV-1 positive individual 
(right panels). 10^  cells were incubated in the presence or absence of 
lOpg/ml aCD4 or aCXCR4 or both for 30 min at 37°C and were then 
transferred to a 96 well plate previously coated with 50 pg/ml sheep anti­
mouse immunoglobulin. Percentages of apoptotic cells are indicated in the 
lower right comer.
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PBLs from an HIV-1 infected or a healthy individual were incubated in the 
presence or absence of either aCD4 or aCXCR4 or both. Apoptosis was induced as 
described in IL2.3.9 and was assessed 24 h following stimulation. Apoptosis was 
determined via FSC/SSC analysis, as morphological criteria provide a reliable method 
of evaluation of the previously described “novel” type of cell death as well as classical 
apoptosis. Moreover this method requires little patient material.
Freshly isolated PBLs from an HIV-1 individual showed low levels of 
spontaneous apoptosis after 24 h incubation in RPMI medium and were resistant to 
apoptosis induced via CD4 and CXCR4. PBLs from an HIV-L individual showed high 
levels of spontaneous apoptosis as it has been previously described (Gougeon et al., 
1993) as well as susceptibility to CD4 and CXCR4 mediated cell death (figure III.l). 
Each receptor could individually mediate apoptosis while engagement of both receptors 
showed an additive effect. These data suggested a role for CD4/CXCR4 mediated 
apoptosis in HIV-1 induced T cell depletion.
I.3 Kinetics of aCD4 and aCXCR4 induced apoptosis
Initially aCD4/aCXCR4 induced apoptosis was determined after 24 h. 
However, the “novel” apoptosis previously described in the T cell line HPBALL 
(Lipoldova et al., 1989) and in the CD4 and CXCR4 transfected B cell line BJAB 
showed rapid kinetics. The apoptotic process was complete as early as 2h following 
stimulation. In order to determine whether similar kinetics applied to primary cells from 
HIV-1 infected individuals, apoptosis was evaluated at several time points after 
stimulation.
Freshly isolated PBLs from an HIV-1 infected individual or a healthy control 
were incubated in the presence or absence of aCD4 or aCXCR4 as described in
II.2.3.9. Apoptosis was evaluated by FSC/SSC analysis at the time points indicated in 
figure III.2.
In contrast to cell lines, no apoptosis induction via CD4 or via CXCR4 was 
observed at early time points. Apoptosis induction was initiated approximately 8 h 
following stimulation with a maximal effect observed after 18 h. Further incubation for 
24 or 48 h did not alter the levels of apoptotic cells. Therefore apoptosis was 
determined after 18 h in all further experiments.
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Fig. III.2: Kinetics of aCD4 and aCXCR4 induced cell death. Kinetic 
analysis of apoptosis induced by aCD4 (A), or aCXCR4 (B) in PBLs from 
a HIV-1^ (■) and a HIV-L (0) individual. Cell death was determined by 
FSC/SSC analysis at the indicated time points. Specific apoptosis was 
calculated as described in Materials and Methods (see II.2.3.3). One 
representative experiment of 10 performed in triplicates is shown.
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1.4 Evaluation of CD4 and CXCR4 mediated apoptosis in a representative cohort 
of HIV-1 infected individuals
Since the initial findings suggested that PBLs from HIV-1 infected individuals 
were sensitive to aCD4/aCXR4 induced apoptosis, a larger number of patients was 
examined. However, induction of CD4 and CXCR4 mediated apoptosis showed high 
variability between different HIV-1 infected individuals. Following an initial evaluation 
of apoptosis induction in 50 HIV-1 infected individuals and 30 healthy controls, 
«cutpoint» estimates of specific apoptosis values were calculated (Miller & Siegmund, 
1982). These values represented limits above which apoptosis induction was considered 
statistically significant (see n.2.6). The following values were determined for CD4, 
CXCR4 and CD4/CXCR4 induced apoptosis:
Stimulus Cutpoint estimate (% specific 
apoptosis)
95% Confidence Interval
aCD4 4.6 1.8 to 7.3
aCXCR4 3.9 1.1 to 7
aCD4+aCXCR4 5.3 3.2 to 7.7
Therefore in the overall patient cohort, which comprised 202 individuals, only 
apoptosis values higher than the cutpoint estimates were considered.
In the overall group of individuals examined, specific aCD4, aCXCR4 and 
aCD4/aCXCR4 triggered cell death was significantly higher in PBLs from HIV-R than 
from HlV-1 individuals with P values < 0.001 in all cases (figure 111.3). aCD4 
treatment induced 5.3 % specific apoptosis (mean, 3.9 to 6.6) and aCXCR4 
treatment induced 5.53 % specific apoptosis (mean, Cl^  ^ 3.8 to 7.2) in HIV-T, n= 202, 
versus 1.76 % (mean, Cl^  ^0.94 to 2) and 0.11% (mean, Cl^  ^-1 to 0.73), respectively in 
HlV-1 individuals, n= 78. Triggering of both CD4 and CXCR4 receptors induced 6.96 
% apoptosis (mean, 5.7 to 8.25) in HIV-R versus 0,89 % (mean, Cl^  ^0.05 to 1.7) in 
HlV-1 subjects.
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Fig. III.3: CD4/CXCR4 mediated apoptosis in a cohort of HIV-1 
infected individuals. aCD4, aCXCR4 and aCD4/aCXCR4 induced 
apoptosis is significantly higher in PBLs from 202 HIV-L individuals 
(shaded plots) than from 78 healthy control subjects (blank plots) (P values 
< 0.001). Apoptosis was determined by FSC/SSC analysis 18 h after 
incubation with mAbs against the receptors. Specific apoptosis was 
calculated as described in Materials and Methods (II.2.3.3). Thin lines 
represent the median while thick lines represent the mean.
1.5 Effect of clinical and immunological parameters on apoptosis induction
Since a high variability was observed in apoptosis induction between different 
HIV-1 infected individuals, possible correlations with clinical and immunological 
characteristics of the patients were assessed. It was hypothesized that patients with high
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viral load and low CD4 counts show higher levels of CD4/CXCR4 mediated apoptosis. 
The Wilcoxon rank sum test was used to evaluate the effect of CD4 counts, viral load, 
treatment and stage of the disease of the HIV-1 infected individuals on the induction of 
apoptosis. The Kruskall Wallis test was used to evaluate the effect of the therapy 
regimen. In the overall group of patients no statistically significant correlation could be 
established between any of these parameters and levels of PBL apoptosis. Interestingly, 
however, a statistically significant correlation (P<0.05) was found between high viral 
load (above 5000 copies/ml) and high levels of CXCR4 and CD4/CXCR4 induced 
apoptosis in patients which were not under treatment (therapy naive).
1.6 HAART leads to a decrease in aCD4/aCXCR4 induced apoptosis
It has been previously reported that HAART therapy decreases apoptosis in lymphoid 
tissue and in PBLs of HIV-1 infected individuals (Badley et al., 1998; Badley et al., 
1999). Although no correlation could be established between apoptosis induction and 
therapy regimen per se, the effect of therapy initiation/change on CD4/CXCR4 
apoptosis was investigated. Within the timeframe of the study, the induction of 
aCD4/aCXCR4 apoptosis was repeatedly assessed in PBLs from some individuals 
(n=28). The characteristics of this patient subgroup are shown in table III.2. These 
individuals could be subdivided into two groups, group A: subjects with no change in 
their therapy regimen between the different measurements (n=19), group B: subjects 
that were either initiated into therapy (ART or HAART) or had a change/addition in one 
or more components of their therapy regimen (n=9). In order to evaluate the effect of 
change in therapy on specific apoptosis a linear regression analysis was performed. As 
shown in figure III.4 initiation to HAART regimen significantly reduced, but did not 
abrogate, aCXCR4 and aCD4/aCXCR4 induced apoptosis (P<0.05).
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HIV-1^
(repeated patients)
No. of patients 28
Age (years)' 38.3 ± 9.6
Sex (F/M) 12/16
Viral load (log copies/ml)' 4.66 ± 5
CDL cells (cells/pl)' 438.5 ±217.3
CDS" cells (cells/pl)' 1088.6 ±593.4
CD4V CDS" ratio' 0.46 ± 0.28
Treatment^ Naive (n=10)
ART, double (n=3)
ART, triple (n=2)
Stage (CDC 1993)'
HAART, triple + PI (n=13)
A2 (n=2)
B1/B2/B3 (n=4/17/3)
C1/C2 (n=l/I)
Table IIL2 : Characteristics of repeated patients. * numbers are mean ± SD 
^ART: antiretroviral therapy; double, triple: combinations of two or three 
nucleoside or non-nucleoside analogues, HAART: highly active ART, PI: 
protease inhibitor  ^CDC centres of disease control, classification of 1993 in 
n=2 patients the viral load was below 50 copies/mL (detection limit), bDNA 
Test (Chiron company)
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Fig. III. 4 : Effect of therapy change on aCD4/aCXCR4 induced apoptosis.
Percentages of change in the induction of specific apoptosis after control Ab 
(crosslinking Ab), CXCR4 or CD4/CXCR4 stimulation in two groups of HIV-1^ 
individuals. Group A (blank plots) represents patients with no change in therapy , 
Group B (shaded plots), patients initiated into a more complex therapy. Thin lines 
represent the median while thick lines represent the mean.
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Features of aCD4/aCXCR4 induced apoptosis
2.1 Role of the CD95-, TNF- and TRAIL- systems in aCD4/aCXCR4 mediated 
apoptosis
aCD4 and aCXCR4 induced apoptosis in HPBALL and BJAB cells was found to 
be independent of the CD95, TNF and TRAIL death systems. The HPBALL cell line, 
however, is insensitive to CD95 and TNF mediated apoptosis. Moreover the rapid 
kinetics of apoptosis induction could be limiting for the upregulation of the ligands of 
these receptors.
HIV-1^
(Study of apoptosis 
inhibition)
No. of patients 40
Age (years)* 43.7 ± 10
Sex (F/M) S/32
Viral load (log copies/ml) * 4.42 ± 4.94
CD4^ cells (cells/pL) * 544 ± 269.4
CDS" cells (cells/pL)* 10S3± 449.3
CD4"/CDS" ratio* 0.57 ± 0.4
Treatment ^ Naive (n=7)
ART, double (n=4)
ART, triple (n=24)
HAART, triple + PI (n=5)
Stage (CDC 1993)' A1 (n=2)
B1/B2/B3 (n=13/21/3)
C3 (n=l)
Table III.3: Patient characteristics, numbers are mean ± SD ^ART: 
antiretroviral therapy; double, triple: combinations of two or three 
nucleoside or non-nucleoside analogues, HAART: highly active ART, PI: 
protease inhibitor ^CDC centres of disease control, classification of 1993 in 
n=3 patients the viral load was below 50 copies/mL (detection limit), 
bDNA Test (Chiron company)
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The CD95, TNF and TRAIL systems have been suggested to play a role in T cell 
apoptosis during HIV-1 infection. It was therefore investigated whether the aCD4, 
aCXCR4 induced apoptosis observed in PBLs from HIV-1 infected individuals was 
dependent on these receptor systems. PBLs from 40 patients were used for these 
experiments (for patient characteristics see table III.3).
Initially both aCD4 and aCXCR4 induced apoptosis were examined and similar 
results were obtained for both receptors. However, due to limitations in patient material 
apoptosis was induced by aCD4+aCXCR4 in these experiments.
2.1.1 aCD4/aCXCR4 induced apoptosis is independent of the CD95 system
In order to investigate the role of CD95 in aCD4/aCXCR4 mediated apoptosis 
an inhibitor of the CD95 system , CD95-Fc, was used (Dhein et al., 1995) (see II. 1.8). 
PBLs were incubated in the presence or absence of CD95-Fc for 40 min at 37°C, 
followed by stimulation with aCD4 and aCXCR4 (see II.2.3.9). As a control, Jurkat 
cells were preincubated with CD95-Fc and apoptosis was induced via incubation with 1 
pg/ml (xApol. Jurkat cell apoptosis was measured after 10 h while apoptosis of PBLs 
after 18 h, via FSC/SSC analysis.
In the overall group of HIV-1 infected individuals tested specific 
aCD4/aCXCR4 induced apoptosis was not significantly inhibited by CD95-Fc 
(P=0.17) (figure III.5). In contrast CD95 mediated apoptosis was entirely blocked by 
CD95-FC in Jurkat cells thus demonstrating the functionality of the inhibitor.
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Fig. III.5: aCD4/aCXCR4 induced apoptosis is independent of the 
CD95 system.
(A) Specific aApol induced apoptosis in Jurkat cells in the presence (black 
bars) or absence (white bars) of 10 pg/ml CD95-Fc. The experiment was 
performed in triplicates and the results are presented as mean±SD.
(B) Specific aCD4/aCXCR4 induced apoptosis, in PBLs from 40 HIV-1 
infected individuals, in the presence (Y axis) or absence (X axis) of 50 
pg/ml CD95-FC.
2.1.2 aCD4/aCXCR4 induced apoptosis is independent of the TNF system
The TNF system has been suggested to contribute to apoptosis induced by CD4 
(Han et ah, 1996) and recently also via CXCR4 (Herbein et ah, 1998). In order to 
examine the contribution of the TNF system in the present experimental system the 
TNF-R2-FC construct was used which inhibits receptor-ligand interactions.
Apoptosis was induced in PBLs from 40 HIV-1 infected individuals as 
previously described with an additional preincubation in the presence or absence of 
TNF-R2-FC (see II. 2.3.9).
As a control for the activity of the inhibitor the murine cell line L929 was used which 
can be sensitized to TNFa induced cell death in the presence of Actinomycin D. 2x10^
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L929-cells were incubated with 1 |ig/ml actinomycin D for 24 h at 37°C, followed by a 
further 30 min incubation in the presence or absence of TNF-R2-Fc and further addition 
of 10 ng/ml TNFa.
Apoptosis of PBLs from HIV-1 infected patients was measured after 18 h by 
FSC/SSC analysis while L929-cell apoptosis was determined after 24 h using the MTT 
test. In the overall group of patients tested no significant inhibition of aCD4/aCXCR4 
induced apoptosis was observed (figure III.6). In contrast, TNFa induced apoptosis of 
L929 cells was entirely blocked thus demonstrating the functionality of the construct 
used.
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Fig. III.6: aCD4/aCXCR4 induced apoptosis is independent of the TNF 
system. (A) Specific TNFa induced apoptosis in L929 cells in the absence 
(white bars) or presence (black bars) of 10 pg/ml TNF-R2-Fc. The 
experiment was performed in triplicates and the results are presented as 
mean±SD. (B) Specific aCD4/aCXCR4 induced apoptosis, in PBLs from 
40 HIV-1 infected individuals, in the presence (Y axis) or absence (X axis) 
of 30 pg/ml TNF-R2-FC.
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2.1.3 aCD4/aCXCR4 induced apoptosis is partially dependent on the TRAIL 
system
Recent data have also suggested a potential role for TRAIL in apoptosis in HIV- 
1 infected patients (Katsikis et al., 1997; Jeremias et al., 1998). The contribution of the 
TRAIL system in aCD4/aCXCR4 induced apoptosis was evaluated by using the 
TRAIL-R2-FC inhibitor. Apoptosis of PBLs from HIV-1 infected individuals was 
induced as previously described (II.2.3.9) in the presence or absence of TRAIL-R2-Fc. 
As a control, Jurkat cells were incubated overnight with 0.5 pg/ml leucine zipper 
TRAIL (LZT), in the presence or absence of TRAIL-R2-Fc.
(g
O)(AO
CLO
CL
(0
O
100
7 5 -
50
oQ)
w 25
0
+■
LZT +
TRAILR2FC -
+
+
B
o
(g
'co
a
(0
o
(/>
u_
CM
a:_i
<  40
0:
I-
o
Q)OcQ)U)
2 OO
CL
Q) >00
c
10 20 30 40 50
% specific  a p o p to s is
Fig. III.7: aCD4/aCXCR4 induced apoptosis is partially dependent on 
the TRAIL system. (A) Specific LZT induced apoptosis in Jurkat cells in 
the presence (black bars) or absence (white bars) of 3 pg/ml TRAIL-R2-Fc. 
The experiment was performed in triplicates and the results are presented as 
mean±SD. (B) Specific aCD4/aCXCR4 induced apoptosis, in PBLs from 
40 HIV-1 infected individuals, in the presence (Y axis) or absence (X axis) 
of 30 pg/ml TRAIL-R2-FC.
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As shown in figure IIL7 LZT induced apoptosis was almost completely inhibited 
by TRAIL-R2-FC. aCD4/aCXCR4 induced apoptosis in PBLs was only partly inhibited 
by TRAIL-R2-Fc. This partial inhibition was statistically significant (P<0.001) in the 
overall patient group and showed high variability. More specifically TRAIL-R2-Fc 
inhibited apoptosis in 16 out of 40 patients examined, with percentages of inhibition 
ranging from 10.7 to 79.8 %.
2.1.3.1 Apoptosis inhibition by TRAIL-R2-Fc correlates with the patient viral load
Inhibition of aCD4/aCXCR4 induced apoptosis by TRAIL-R2-Fc was restricted 
to some patients and within this patient subgroup levels of inhibition were highly 
variable. Possible correlations between the clinical and immunological features of the 
patients and apoptosis inhibition were examined. The effect of CD4 counts, viral load 
and therapy on the inhibition of CD4/CXCR4 mediated apoptosis was investigated. A 
statistically significant correlation (P<0.05) was found between high levels of inhibition 
via TRAIL-R2-FC and high viral load (>5000 copies/ml) (figure III.8).
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Fig. III.8: Apoptosis inhibition by TRAIL-R2-Fc correlates with the patient 
viral load.
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2.2 Role of caspases in aCD4/aCXCR4 induced apoptosis
2.2.1 The pancaspase inhibitor BD-fmk partly inhibits aCD4/aCXCR4 induced 
apoptosis
In order to investigate the role of caspases in aCD4/aCXCR4 induced apoptosis 
in PBLs from HIV-1 infected patients the caspase inhibitor BD-fmk was used. The 
peptide BD-fmk competes with the natural substrates of all, so far known, caspases for 
the caspase binding site. The fluoromethylketone(fmk) group binds irreversibly to the 
active centre of the caspases, thus inhibiting the processing of the natural substrates. For 
these experiments PBLs from the same patient subgroup as for the experiments with 
the CD95, TNF, and TRAIL systems were used (table III.3).
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Fig. III.9: aCD4/aCXCR4 induced apoptosis is partly dependent on 
caspases. (A) Specific ocApol induced apoptosis in H9 cells in the presence 
(black bars) or absence (white bars) of 20 pM BD-fmk. The experiment was 
performed in triplicates and the results are presented as mean±SD. (B) 
Specific aCD4/aCXCR4 induced apoptosis, in PBLs from 40 HIV-1 
infected individuals, in the presence (Y axis) or absence (X axis) of 50 pM 
BD-fmk.
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aCD4/aCXCR4 apoptosis was induced as previously described (see 11.2.3.9) but 
the samples were additionally preincubated in the presence or absence of BD-fmk. As a 
control for the functionality of BD-fmk, H9 cells were also preincubated in the same 
manner followed by addition of Ipg/ml oApol. Apoptosis of H9 was measured after 12 
h while apoptosis of PBLs was measured afer 18 h by FSC/SSC analysis. In the H9 
cells, ocApol induced apoptosis was entirely blocked by BD-fmk .
aCD4/aCXCR4 induced apoptosis was partly inhibited by BD-fmk. This partial 
inhibition was statistically significant (P<0.01) but showed great variability within the 
patient group. More specifically, BD-fmk inhibited CD4/CXCR4 mediated apoptosis in 
15 patients with percentages of inhibition ranging from 11.9 to 93 %. These data 
suggested that in certain patients aCD4/aCXCR4 induced apoptosis is partly mediated 
by a caspase dependent pathway. Higher concentrations of BD-fmk (up to 100 pM) 
gave similar results.
2.2.2 Lack of Caspase-8 cleavage during CD4/CXCR4 mediated apoptosis
In the majority of the HIV-1 infected individuals examined aCD4/aCXCR4 
induced apoptosis in PBLs was caspase independent . In order to verify this finding, 
caspase 8 processing was tested by immunoblotting in PBL lysates from some 
representative patients where no inhibition of apoptosis via BD-fmk was seen.
Caspase-8 is the first molecule of the caspase cascade, providing a molecular 
link between the Death Inducing Signaling Complex (DISC) and the downstream 
caspases. Formation of the DISC comprising the adaptor molecule F ADD and caspase-8 
results in the release of active caspase-8 at the DISC and cleavage of various 
intracellular death substrates.
1x10* PBLs from HIV-1 infected individuals were incubated in the presence or 
absence of aCD4+aCXCR4 and apoptosis was induced as previously described. Cell 
lysates were prepared (see 11.2.5.1) at various time points following stimulation to 
exclude lack of detection of the active subunit of caspase 8 due to degradation. 50 jig of 
protein from each sample were loaded on a 12% gel. For the detection of caspase 8 the 
anti-caspase 8 antibody C-15 was used. As a control Jurkat cells were incubated for 6 h 
in the presence or absence of l}Xg/ml cxApol.
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In accordance with the data obtained with the BD-fmk inhibitor, no cleavage of 
caspase 8 to its active subunits (p43, p41 and p i8) was seen during aCD4/aCXCR4 
induced apoptosis of PBLs from HIV-infected patients at the various time points 
indicated (figure III. 10). The active p i8 subunit was, however, readily detected after 
stimulation of the Jurkat cells with otApol.
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Fig. III.IO: Lack of caspase 8 activation during aCD4/aCXCR4 
induced apoptosis. Western blot analysis of Caspase 8 in cellular lysates of 
10* cells. PBLs from HIV-1 positive individuals were either left untreated (- 
) or treated (+) with aCD4/aCXCR4 and proteolytic processing of caspase 
8 was determined at the indicated time points. As a positive control Jurkat 
cells were either left untreated or treated for 5 hours with Ipg/ml aApol. 
The positions of the active fragments p43, p41 and pl8 of caspase 8 are 
indicated. Western blot analysis of F ADD is shown at the lower pannel as a 
loading control.
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2.2.3 Lack of PARP cleavage during CD4/CXCR4 mediated apoptosis
PARP is one of the earliest target substrates of Caspase-3 like caspases. 
Cleavage of PARP into an 85 and 31 kD fragment has been described in all apoptotic 
processes mediated by caspases.
Processing of PARP was also investigated during aCD4/aCXCR4 induced 
apoptosis of PBLs from HIV-1 infected individuals by western blot analysis as 
described for Caspase-8. For PARP detection the anti-PARP antibody CIIIO was used.
Jurkat HIV-1 infected PBLs
time(h)
aCD95
aCD4/
aCXCR4
8 18
+ ■ + + KDa
II,,'",# # Iim
Fig. III. 11: Lack of PARP cleavage during aCD4/aCXCR4 induced 
apoptosis. Western blot analysis of PARP cleavage. PBLs and Jurkat cells 
were treated as in fig. III.IO and PARP cleavage was determined after the 
indicated time points. PARP and its cleavage product are indicated. A 
shorter exposure of the blot is shown in the lower pannel to compensate for 
the different amounts of protein loaded.
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PARP clevage was not observed during aCD4/aCXCR4 induced apoptosis at 
the various time points indicated (figure III. 11) while the p85 cleavage product was 
readily detected in the control Jurkat cells. Due to unequal loading between the Jurkat 
cells and the HIV-D PBLs a shorter exposure of the blot is also presented.
2.3 Lack of DNA fragmentation during CD4/CXCR4 mediated apoptosis
DNA fragmentation is one of the characteristic features of “classical” apoptosis. 
However, DNA fragmentation was not observed during the “novel” type of caspase 
independent cell death. In order to investigate whether DNA is degraded during 
aCD4/aCXCR4 induced apoptosis in PBLs from HIV-1 infected patients the Nicoletti 
method was used (see II.2.3.4).
Apoptosis via CD4 and CXCR4 was induced as previously described and 
assessed after 18 h. The cells were subsequently lysed overnight in a Triton-X-100/PI 
containing buffer. As a control, PBLs from a healthy individual were incubated for 12h 
in the presence or absence of Ipg/ml ocApol. The cells were previously cultured for 24 
h in the presence of PHA and IL-2. PHA was then washed away and the cells were 
cultured for 5 days in IL-2 medium in order to increase sensitivity towards ocApol 
induced apoptosis.
As shown in figure 111.12 induction of apoptosis by ocApol in PBLs from a 
healthy individual lead to degradation of the cellular DNA (panel E). In contrast, no 
subGI DNA content could be detected in aCD4 or aCXCR4 stimulated PBLs from a 
HIV-1 infected individual (panels B, C).
In order to ensure that apoptosis was induced via CD4 and CXCR4 an aliquot of 
the samples was taken prior to lysis and apoptosis induction was evaluated via FSC/SSC 
analysis. The percentages of dead cells were: 18% in unstimulated PBLs, 31.4% in 
aCD4 stimulated and 35% in aCXCR4 stimulated cells. The ocApol treated PBLs from 
the healthy control showed 85.8% apoptosis. In these samples, the percentage of cell 
nuclei with fragmented DNA, measured via the Nicoletti assay, was lower than the 
percentage of dead cells, measured via FSC/SSC analysis (74.4% versus 85.8%). This is 
due to the fact that nuclei with fragmented DNA are only transiently measurable.
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Fig. III. 12: Lack of DNA fragmentation during CD4/CXCR4 mediated 
apoptosis. The DNA content of unstimulated (A), aCD4 stimulated (B) 
oraCXCR4 stimulated (C) PBLs from a HIV-1 infected individual and 
unstimulated (D), or ocApol stimulated (E) PBLs from a healthy individual, 
was assessed via flow cytometry. The percentages of nuclei with fragmented 
DNA are given.
Therefore, DNA degradation in HIV-T PBLs was assessed at different time 
points after stimulation via CD4 and CXCR4. The obtained results were similar to those 
presented in figure III. 12.
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2.4 Involvement of mitochondria in aCD4/aCXCR4 induced apoptosis
Apoptosis is accompanied by signs of mitochondrial membrane permeabilization 
(MMP), including loss of the inner mitochondrial transmembrane potential (A'Pm) and 
the release of soluble intermembrane proteins via the outer mitochondrial membrane 
(Kroemer and Reed, 2000; Gross et ah, 1999).
contro l
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Fig. III.13: Cytochrome c is released during aCD4/aCXCR4 induced 
apoptosis. Cytochrome c (green fluorescence) is confined to the 
mitochondria (red fluorescence) in unstimulated PBLs (left panels) while it 
translocates to the cytosol in aCD4/aCXCR4 stimulated PBLs (right 
panels). A representative experiment of three is shown.
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MMP results in the translocation of cytohrome c (Cyt-c) from the mitochondrial 
intermembrane space to the cytosol and subsequent cell death (Green and Reed, 1998).
In order to investigate the role of mitochondria in aCD4/aCXCR4 induced apoptosis in 
PBLs from HIV-1 infected individuals, cytochrome c release was assessed by 
immunofluorescence staining and confocal microscopy.
Apoptosis via CD4/CXCR4 was induced as previously described and 
cytochrome c release was assessed 12 h after stimulation. As shown in figure 111.13 in 
unstimulated PBLs (control) Cyt-c is confined to the mitochondria as seen by the 
distinct staining pattern and the colocalisation of the mitochondrial marker and Cyt-c 
fluorescence signal (lower left panel). Upon stimulation with aCD4/aCXCR4 a more 
diffuse staining pattern and no colocalisation of the fluorescence signals could be seen 
(lower right panel). This corresponded to cytochrome c being released in the cytosol.
2.5 Overview of the characteristics of aCD4/aCXCR4 induced apoptosis in 
PBLs from HIV-1 infected individuals
In this chapter the features of aCD4/aCXCR4 induced apoptosis in PBLs from 
HIV-1 infected individuals were investigated. Apoptosis mediated via CD4 and CXCR4 
was found to be independent of the CD95 and TNF system and no DNA degradation 
was observed. The dying cells exhibited the characteristic mophological changes of 
apoptotic cells as evaluated via FSC/SSC analysis. Although due to technical limitations 
the reduction of the 'Em could not be measured in the patient samples, cytochrome C 
was found to be released during apoptosis. This showed that mitochondria have a 
potential role in aCD4/aCXCR4 induced apoptosis. These findings were in accordance 
with the data previously obtained in cell lines.
However, aCD4/aCXCR4 induced apoptosis in HIV-L PBLs showed slower 
kinetics than in cell lines. It was found to be partly dependent on the TRAIL system. 
Moreover it was partly inhibited by BD-fmk thus showing a partial dependence on 
caspases. Nevertheless, in the majority of the patients tested aCD4/aCXCR4 induced 
apoptosis was independent of caspases as no caspase 8 and PARP cleavage were 
observed.
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Table IIL4 gives an overview of the characteristics of aCD4/aCXCR4 induced 
apoptosis in HIV-T PBLs in comparison to “classical” aCD95 induced apptosis and to 
the “novel” type of aCD4/aCXCR4 induced apoptosis found in cell lines.
Characteristics
aCD95-
induced
apoptosis
aCD4/ 
aCXCR4- 
induced 
apoptosis in 
cell lines
aCD4/ 
aCXCR4- 
induced 
apoptosis in 
H IV -r PBLs
Kinetics -12 h ~2h —18 h
DNA degradation 4- - -
Cytoplasmic condensation + 4- 4-
FSC/SSC changes + 4- 4-
Early loss of membrane assymetry + 4- ND
Reduction of the 'Em -f- 4- ND
Cytochrome C release + 4- 4-
Caspase-8 cleavage 4- - -
PARP cleavage 4- - -
Inhibition via BD-fmk 4- - partial
Table III.4 : Characteristics of aCD4/aCXCR4 induced apoptosis in 
HIV-T  ^ PBLs in comparison to cell lines and to aCD95 induced 
apoptosis. (ND) not determined due to technical limitations because of 
fixation of HIV-L PBLs.
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3 Sensitisation of PBLs from healthy individuals towards 
aCD4/aCXCR4 induced apoptosis via activation
In previous studies, PBLs from healthy individuals were also found to undergo 
caspase independent apoptosis upon stimulation via CD4 and CXCR4 (Bemdt et al., 
1998). However, these findings appear to be contradictory to the data presented in 
chapter 1. The experiments presented here were designed in order to investigate whether 
the activation state of the PBLs determines sensitivity versus resistance towards 
aCD4/aCXCR4 induced apoptosis. In order to gain more insight into the potential role 
of aCD4/aCXCR4 induced apoptosis the sensitivity of different PBL subpopulations 
was also assessed.
3.1 Mitogenic stimulation renders PBLs sensitive to aCD4/aCXCR4 induced 
apoptosis
PBLs were isolated from whole blood of healthy individuals as described in 
materials and methods (II.2.2.1). The cells were subsequently cultured for 12 h in RPMI 
medium containing 10 ng/ml of the mitogen PHA-P. PHA-P was then washed away and 
the cells were kept in RPMI medium supplemented with 25 U/ml IL-2. 10^  PBLs either 
freshly isolated or PHA-P/IL-2 stimulated were incubated in the presence or absence of 
aCD4 or aCXCR4.
Apoptosis was induced as previously described (see II.2.3.9) and measured via 
FSC/SSC analysis 2 h following stimulation. As shown in figure 111.14 freshly isolated 
PBLs were not sensitive to aCD4 or aCXCR4 induced apoptosis. PBLs stimulated via 
PHA-P/IL-2 for 24 or 48 h showed sensitivity to apoptosis mediated via CD4 and 
CXCR4. Sensitivity declined in PBLs kept in IL-2 medium for 72h and high levels of 
spontaneous apoptosis were usually observed in these samples.
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Fig. III. 14: Mitogenic stimulation renders PBLs sensitive to
aCD4/aCXCR4 induced apoptosis. PBLs either freshly isolated or 
stimulated with PHA-P/lL-2 for 24, 48 or 72 h were incubated with 10 
pg/ml aCD4 (grey bars) or aCXCR4 (white bars) and a crosslinking 
secondary antibody. Specific apoptosis was calculated as described in 
Materials and Methods. One representative experiment of 10 performed in 
triplicates is shown.
3.2 CD4  ^activated PBLs are sensitive to aCD4 and aCXCR4 induced apoptosis
3.2.1 Immunomagnetic separation of PBL subpopulations
CD4, CD8, CD45RA and CD45RO negative PBL subpopulations were obtained 
as described in 11.2.2.2. 5x10’ PBLs previously incubated in lL-2 containing medium for 
24 h were incubated with 25 pg/ml of a monoclonal antibody against either CD4 (10T4) 
or CD8 (0KT8) in order to obtain CD4 and CDS negative populations respectively. For 
the CD45RA and RO negative subpopulations the HI 100 and UCHLl antibodies were 
used. Additionally, an antibody against CD 16 (3G8) and one against CD 19 (HD37) 
were included in order to deplete the CD 16 expressing NK cells and granulocytes and 
the CD 19 expressing B cells.
The separation process here described is based on «negative selection» of PBL 
subpopulations where the non-desired fraction is depleted by binding of the appropriate 
antibody to the magnetic beads while the remaining fraction is the one of interest. For
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simplicity the obtained populations were designated as CD4^, CD 8\ CD45RA^ and 
CD45R0^ (corresponding to CDS', CD4", CD45R0" and CD45RA" cells respectively).
3.2.2 Characterisation of the PBL subpopulations via surface staining
3.2.2.1 Characterisation of CD4^ and CD8^ PBL subpopulations
In order to assess the purity of the subpopulations obtained via immunomagnetic 
separation the surface expression of the antigen of interest was evaluated by 
immunofluorescence staining and flow cytometry (see II.2.2.3.1). The CD4 and CDS 
receptors were detected by using FITC-conjugated antibodies against CD4 (HP2/6) or 
CDS (OKTS) (provided by Dr. G. Moldenhauer, German Cancer Research Centre).
The CD4 and CDS expression levels of the PBL subpopulations as well as of 
unseparated PBLs are shown in table III.5. The CD4^ and CDS^ subpopulations were > 
95 % pure.
Population
aCD4 aCD8
[%] MFI [%] MFI
PBL 64.5 38.2 22.4 147.6
CD4+ 96.4 33.1 4.5 29.3
CD8^ 3.8 14.6 97.9 173.3
Table III.4 : CD4 and CDS expression in unseparated PBLs and PBL 
subsets. The numbers indicate percentages of cells that interact with the 
monoclonal antibodies [%] and mean fluorescent intensity (MFI) acquired 
by flow cytometry. The values indicated in the table are representative of 
triplicates.
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3.2.2.2 Characterisation of CD45RA^ and CD45RO PBL subpopulations
The surface expression of the antigens of interest was assessed by 
immunofluorescence staining and flow cytometry. The HI 100 and UCHLl antibodies 
were used for the detection of CD45RA and CD45RO respectively, followed by a PE- 
conjugated secondary antibody. As a control, cells were incubated with the secondary 
antibody alone. As shown in table III. 5 the subpopulations obtained via 
immunomagnetic separation were > 95 % pure.
The CD45RA and RO markers were used in order to define naive versus 
activated PBLs. In order to further characterise the naive or activated phenotype of the 
obtained subsets the expression levels of the activation markers CD25, CD69 and CD95 
were examined. CD45RO"  ^cells expressed high levels of all three markers in contrast to 
CD45RA" cells.
CD45RA^ CD45RO^
[%] MFI [%] MFI
control 5.4 14.9 1.46 11.4
CD45RA 97.8 103.1 5.8 41.5
CD45R0 6.7 34.8 96.7 93.1
CDS 97.3 92.8 98.9 107
CD8 31.2 159.5 9.2 65.3
CD25 9.4 20.7 69.7 31.9
CD69 4.1 21.3 73.8 46.2
CD95 8.8 17 95.8 32.2
Table III.5 : Phenotypic characterisation of CD45RA"  ^ and CD45RO 
PBL subsets. The numbers indicate percentages of cells that interact with 
the monoclonal antibodies. [%], and mean flrorescent intensity (MFI) 
acquired by flow cytometry. The values indicated in the table are 
representative of triplicates.
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Subsequently, CD4 and CXCR4 expression levels were assessed in the CD45RA" 
and CD45RO" subpopulations in comparison to unseparated PBLs. For the detection of 
CXCR4 the 12G5 antibody was used. As shown in table III.6 the proportion of CD4 
expressing cells in the CD45RA^ population was approximately 50% less than in the 
CD45RO^ population (46.2 % versus 81.7 %). CXCR4 was also expressed at a 3 fold 
higher level in the CD45RO^ subpopulation (54.5 % versus 16.5 %).
Population
aCD4 aCXCR4
[%] MFI [%] MFI
PBL 65.8 38.2 32.5 20.8
CD45RA" 46.2 34.7 16.5 19
CD45RO" 81.7 36.6 54.5 24
Table III.6 : CD4 and CXCR4 expression in PBLs and CD45RA% 
CD45RO'" subpopulations. The numbers indicate percentages of cells that 
interact with the monoclonal antibodies [%] and mean fluorescent intensity 
(MFI) acquired by flow cytometry. The values indicated in the table are 
representative of triplicates.
3.2.3 Sensitivity of PBL subpopulations to aCD4 and aCXCR4 induced apoptosis
3.2.3.1 CD4  ^lymphocytes are sensitive to aCD4 and aCXCR4 induced apoptosis
The sensitivity of the CD4^ and CD8"^  PBL subpopulations to aCD4 and 
aCXCR4 induced apoptosis was examined. Apoptosis via CD4 and CXCR4 was 
induced as previously described and measured using the PI exclusion assay and flow 
cytometry. In accordance to what has been previously reported only CD4^ cells were 
sensitive to apoptosis mediated via CD4 and CXCR4 (figure III. 15) (Bemdt et al., 
1998).
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Figure III. 15 : CD4  ^ lymphocytes are sensitive to CXCR4 and CD4 
mediated apoptosis. PBLs or CD4\ CDS  ^PBL subsets were incubated with 
10 |ig/ml aCD4 (grey bars) or aCXCR4 (white bars) and a crosslinking 
secondary antibody. Specific apoptosis was calculated as described in 
Materials and Methods. One representative experiment of 3 performed in 
triplicates is shown.
3.2.3.2 CD45RO lymphocytes are sensitive to aCD4 and aCXCR4 induced 
apoptosis
Subsequently, the sensitivity of the CD45RA^ and CD45RO^ PBL subpopulations to 
aCD4 and aCXCR4 induced apoptosis was examined. Apoptosis via CD4 and CXCR4 
was induced as previously described and measured using the PI exclusion assay and 
flow cytometry. As shown in figure III. 16 approximately 30% of the CD45RO\ 
activated lymphocytes were sensitive to apoptosis mediated via CD4 and CXCR4. In 
contrast no apoptosis induction was observed in the CD45RA\ naive lymphocytes 
although they expressed both CD4 and CXCR4 receptors, albeit in lower levels than 
CD45RO" cells.
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Figure III.16 ; CD45RO lymphocytes are sensitive to CXCR4 and CD4 
mediated apoptosis. PBLs or CD45RA\ CD45RO^ PBL subsets were 
incubated with 10 pg/ml aCD4 (grey bars) or aCXCR4 (white bars) and a 
crosslinking secondary antibody. Specific apoptosis was calculated as 
described in Materials and Methods. One representative experiment of 10 
performed in triplicates is shown.
Therefore, as demonstrated by these experiments CD4^ activated lymphocytes are 
susceptible to aCD4 and aCXCR4 induced «novel» type of apoptosis. These findings 
highlight the relevance of this type of apoptosis to HIV-1 pathogenesis since this 
lymphocyte population is the one mainly depleted during infection.
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4 Structure-function studies of the CD4 and CXCR4 receptors
In order to gain some initial insight into the mechanism of CD4 and CXCR4 
mediated apoptosis structure-function studies of the two receptors were carried out. 
These aimed to identify structural determinants of the receptors required for the 
apoptotic signaling and for possible interactions with downstream molecules. For this 
purpose wild type, chimeric or mutant CXCR4 or CD4 receptors were expressed in the 
human B-lymphoblastoid cell line BJAB, as this cell line is CD4 and CXCR4 negative 
and can be stably transfected with high efficiency. Subsequently the sensitivity to 
apoptosis of cells expressing one of the various chimeric and mutant receptors in 
comparison to cells expressing one of the wild type receptors was assessed.
4.1 Structure -function analysis of the CXCR4 receptor
The creation of receptor chimeras, hybrid molecules composed of complementary 
portions of related receptors that have distinguishing biochemical or biological 
characteristics, is a powerfull approach for the identification of domains that impact 
activity.
CXCR4
4442 ^  2442 ^  2244 '
Fig. III. 17: CXCR4-CXCR2 chimeras. Chimeric receptors based on 
CXCR4 and CXCR2 are depicted schematically. Aminoterminal domain 
exchanges were performed at the conserved cysteine residue at position 28 
ofCXCR4.
(Figure redrawn from Lu et al., 1997 PNAS)
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In order to identify regions of CXCR4 required for apoptosis induction chimeric 
molecules between the CXCR4 and CXCR2 receptors were used. These receptors share 
approximately 35% amino acid identity. However, CXCR2 has not been reported to 
serve as a HIV-1 coreceptor.
The following chimeric receptors, where either single or multiple CXCR4 
domains were replaced with corresponding CXCR2 regions, were used: 2444, 4442, 
2442, 2244 (the 2444 and 4442 chimeric receptor cDNAs were provided by Dr. S. 
Peiper, University of Louisville, while the CXCR2 receptor cDNA was provided by Dr. 
Robert Doms, University of Pensylvania), (figure III. 17).
4.1.1 Generation of CXCR4-CXCR2 receptor chimeras and CXCR4 receptor 
mutants
Chimeric receptors composed of CXCR4 and CXCR2 were constructed by the 
PCR-ligation-PCR approach. To create chimeras, complementary cDNAs of the two 
parental receptors were amplified from cDNA templates and the blunt-ended 
amplification products were ligated after phosphorylation. The product encoding the 
desired hybrid was then amplified with the appropriate upstream and downstream 
primers from the respective parental receptors (see II. 1.6.3). Products of the predicted 
size were cloned into the pBS vector, screened and sequenced. The chimeric receptor 
cDNAs were subsequently cloned into the pcDNA3 vector.
In order to study the role of the C-terminal domain of CXCR4 in the 
transmission of the apoptotic signal a deletion mutant receptor (CXCR4 Acyto) was 
used. CXCR4 was truncated at the amino acid 318 by altering the codon 319 into a stop 
codon using standard PCR methods (primers shown in H. 1.6.3).
4.1.2 Generation and characterisation of stable transfectants
The CXCR4 and CXCR2 negative cell line BJAB was used for the generation of 
stable transfectants expressing one of the following receptors: CXCR4 wt, CXCR2 wt, 
2444, 4442, 2442, 2244, CXCR4 Acyto, or the pcDNA3 vector alone. The transfection 
protocol described in II.2.4.9 was followed. Cell surface expression of the molecule of 
interest was tested via immunofluorescence staining. The CXCR2 , 2444, 2442 and
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2244 receptors were detected by using a monoclonal antibody against the amino 
terminus of the CXCR2 receptor (10G2), while the CXCR4, 4442 and CXCR4 Acyto 
receptors were detected by using a monoclonal antibody against the first and second 
extracellular loops of the CXCR4 receptor (12G5). A B-Phycoerythrin conjugated 
secondary antibody was used. The results of the immunofluorescence staining of a 
representative clone from each transfectant group are shown in table III.7 and in figure
m .i8 .
Control aCXCR2 aCXCR4
Cells [%] MFI [%] MFI [%] MFI
BJAB 0.2 18 5.3 15 7.1 11
HPB-ALL 0.83 7.1 - - 80 55.4
Vector (pcDNAS) #5 0.29 4.2 1.7 3.15 5.6 8
CXCR4 wt+ #18 0.41 16 - - 99.3 66.9
CXCR2+ #12 0.42 8.5 98 162.5 - -
CXCR4Acyto+#ll 0.8 25 - - 99.5 773.8
2444+ #12 5.9 12.6 98.7 156.6 - -
4442+ #13 1.7 13.45 - - 98.8 157.1
2442+#12 0.29 14 99.3 401.3 - -
2244+ #5 0.15 3.9 85.7 27.7 - -
Table III.7 : Surface expression of wild type, mutant and cbimeric 
CXCR4 receptors in stable transfectants compared to untransfected 
BJAB and HPBALL cells. The numbers indicate percentages of cells that 
interact with the monoclonal antibodies [%] and mean fluorescent intensity 
(MFI) acquired by flow cytometry. The values indicated in the table are 
representative of triplicates.
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Fig. III.18 : Cell surface expression of wt, mutant and chimeric CXCR4 receptors 
stably expressed in BJAB cells. Surface expression levels of CXCR4, CXCR2 , mutant 
and chimeric receptors were evaluated via flow cytometry after staining with the 
secondary antibody alone (control, white peak) or with an appropriate monoclonal 
antibody (grey peak), (A) vector #3, (B) CXCR4 #6, (C) CXCR2 #12, (D) CXCR4 
Acyto #11, (E) 2444 #12, (F) 4442 #13, (G) 2442 #12, (H) 2244 #5.
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4.1.3 Sensitivity of the transfectants towards aCXCR4 induced apoptosis
The selected transfectants were tested for their sensitivity towards CXCR4 
induced apoptosis. CXCR4 mediated apoptosis was induced as previously described 
(see II.2.3.9). and was evaluated following a 2 h incubation via FSC/SSC analysis. As 
shown in fig.III. 19 the CXCR4 expressing transfectants were sensitive to anti-CXCR4 
induced apoptosis. Stimulation of CXCR2 positive transfectants by anti-CXCR2 did not 
however lead to induction of apoptosis thus validating the choice of this receptor for the 
construction of the chimeric molecules. Replacement of the amino terminus of CXCR4 
up to the conserved cysteine residue at position 28 (chimera 2444) did not affect the 
induction of apoptosis. The same was seen with the chimera 4442 thus indicating that 
the third extracellular loop and the C-terminal of the CXCR4 receptor are also 
dispensable for the apoptotic function. Deletion of the C-terminal domain (mutant 
CXCR4 Acyto) had no effect on anti-CXCR4 induced apoptosis, further indicating that 
this domain is not involved in the apoptotic signaling.
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Fig. III.19: Apoptosis induction in cells expressing wild type, mutant or 
chimeric CXCR4. Apoptosis was assessed by flow cytometry (FSC/SSC 
analysis). The results shown are representative of ten independent 
experiments and the values indicate mean ± SD of triplicates.
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Since the amino terminal domain and the third extracellular loop of CXCR4 
could be individually replaced without ablating transmission of the apoptotic signal it 
was tested whether replacement of both regions is also tolerated. Chimera 2442 
mediated anti-CXCR4 induced apoptosis thus suggesting that the region from the first 
cysteine residue till the third extracellular loop is sufficient for the apoptotic function. In 
order to examine the roles of the first intracellular and extracellular loops in the 
transmission of the apoptotic signal the chimera 2244 was examined. Chimera 2244 did 
not mediate anti-CXCR4 induced apoptosis. This indicated that the area from the 
second intracellular loop till the third extracellular loop is critical for the transmission of 
the apoptotic signal.
4.2 Analysis of CD4 m utant receptors
In order to determine which part of the CD4 receptor plays a role in the 
transduction of the apoptotic signal stable transfectants were generated expressing either 
the CD4 wild type receptor or one of a series of intracellularly truncated CD4 receptors 
bearing a COOH terminal truncation at the indicated amino acid : 431, 429, 419, 411, 
398.
Moreover a CD4 mutant receptor was used bearing a mutation at the p56 Ick 
kinase binding site, designated CD4 Ick-, which prevents the kinase to associate with 
the receptor (all CD4 mutant receptor cDNAs were kindly provided by Dr. Waldemar 
Kolanus, University of Munich) (figure 111.20).
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Fig. III.20: CD4 receptor mutants. Schematic representation of the CD4 
mutants investigated in this study. Truncations at amino acid residues 431, 
429, 419, 411 and 398 partially or totally delete the cytoplasmic tail. The 
CC- to AA substitution in the dicysteine motif 420 and 422 disrupts CD4- 
p56'"" association.
4.2.1 Generation and characterisation of stable CD4 transfectants
For the generation of stable CD4 transfectants BJAB cells were transfected as 
described in II.2.4.9 either with the CD4 wild type(wt) receptor or one of the receptor 
mutants (figure 111.20). As a control BJAB cells were transfected with the empty vector 
pEGFP-Nl. Clonal cell populations were expanded and the cell surface expression of 
the molecule of interest was tested via immunofluorescence staining. The FITC- 
conjugated anti-CD4 antibody RPA-T4 was used for the detection of the receptors and a 
FITC-conjugated mouse IgGl was used as an isotype control.
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Cells
Control aCD4
[%] MFI [%] MFI
BJAB 1.44 10 6,2 11,74
HPB-ALL 0.83 5.4 99.9 283.6
Vector (pEGFP-Nl) #5 0.5 5.3 1.9 6.5
CD4 wt+ #6 2 12.4 97.7 40
CD41ck- + #4 0.9 5 89.5 32.3
398+#15 1.9 12 97.6 87.2
411+#18 0.04 10.3 89.5 100.2
419+ #6 0.3 8.4 97.4 71.7
429+#5 0.5 6.4 92.3 40.9
431+#17 3 12.2 92.3 78.6
Table III.8; Surface expression of wild type and mutant CD4 in 
stable transfectants compared to untransfected BJAB and 
HPBALL cells. The numbers indicate percentages of cells that 
interact with the monoclonal antibodies [%] and mean fluorescent 
intensity (MFI) acquired by flow cytometry. The values indicated in 
the table are representative of triplicates.
The CD4 receptor expressing clones selected via surface staining were 
subsequently expanded and the surface staining was repeated at various time intervals in 
order to determine the stability of expression. According to the surface expression of the 
molecule of interest two to three clones were finally selected. The results of the 
immunofluorescence staining of a representative clone from each receptor transfectant 
are shown in table 111.8 and figure 111.21.
Results 90
M O
‘^ wiiy‘r i‘iwar » i""| J i ii
10" 10  ^ 10^ 10^ 10 
FL1-H
10"  10 '  10"  10"  10 
FL1-H
oE
o
CO
I / I  o
CM
O
FL1-H
M C3 j
10^ 10' 10^ 10^ 10 
FL1-H
I / I  o
10" 10' 10" 10’^  10^ 
FL1-H
I/i o
10° 10  ^ 10^ 10° lo"* 
FL1-H
o
00
w CO
10" 10' lO'^  lO’^  10 
FL1-H
H CO
COoo
CO•M"
CO
CM
CO
FL1-H
Fig. 111.21 :Cell surface expression of CD4 wt or mutants stably expressed in BJAB 
cells. Surface levels of CD4 were evaluated via flow cytometry after staining with an 
isotype control (white peak) or an aCD4 (grey peak) antibody, (A) vector #5, (B) CD4 
wt #6, (C) Ick- #4, (D) 398 #15, (E) 411 #18, (F) 419 #6, (G) 429 #5, (H) 431 #6.
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4.2.2 Sensitivity of the transfectants towards aCD4 induced apoptosis
The selected transfectants stably expressing the CD4 wt or mutant receptors were then 
assessed for their sensitivity towards CD4 mediated apoptosis. CD4 mediated apoptosis 
was induced as previously described (see II.2.3.9) and was measured after a 2 h 
incubation via FSC/SSC analysis. Cells expressing receptors truncated at residue 431 
and 429 underwent apoptosis like those expressing the wild-type CD4 (figure 111.22). 
Similar levels of apoptosis induction were also observed in cells expressing a mutant 
receptor that does not associate with p56'‘^ \ This demonstrated that the apoptotie signal 
is independent of p56''^ signaling activity. This was further confirmed with the CD4 
construct truncated at residue 419 as cells expressing this construct also underwent 
apoptosis. Moreover, apoptosis was induced via the mutant 411 receptor at levels 
comparable to the wild type receptor. Surprisingly, apoptosis could still be induced, 
albeit at significantly lower levels, in cells expressing the 398 mutant where the 
cytoplasmic tail is entirely truncated.
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Fig. III.22 : Apoptosis induction in cells expressing wild type or mutant
CD4. Apoptosis was assessed by flow cytometry (FSC/SSC analysis). The 
results shown are representative of ten independent experiments and the 
values indicate mean ± SD of triplicates.
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5 Investigation of the mechanism of aCD4 induced apoptosis in a 
T cell line system
Preliminary studies on the mechanism of the novel type of CD4 and CXCR4 
mediated cell death, in HPBALL cells, showed that the molecules normally associated 
with signaling by these receptors, p56’"‘ and G,a respectively, were not involved in the 
apoptotie pathway (Bemdt et al., 1998). In order to gain more insight into the signaling 
mechanism of this novel type of cell death the experiments were focused on aCD4 
induced apoptosis as the CD4 receptor provides a simpler experimental system 
compared to the less well characterised and structurally more complex CXCR4 receptor. 
The potential recruitment of signaling molecules to the CD4 receptor complex as well 
as the role of tyrosine phosphorylation in the apoptotie signaling were investigated.
5.1 Optimization of CD4 immunoprécipitation
In order to study the association of signaling molecules the CD4 receptor was 
immunoprecipitated as described in II.2.5.5. To optimize the immunoprécipitation 
conditions different detergent subtances were tested for their ability to solubilise the 
CD4 receptor while retaining complex formation with signaling molecules.
For this purpose 10’ unstimulated HPBALL cells were lysed as described in 
n.2.5.1 using a lysis buffer containing either Triton X-100 (see II. 1.2) or Brij58 (see 
II. 1.2) or Digitonin (10 mM triethanolamine pH 8, 150 mM NaCl, ImM EDTA, 10% 
glycerol, digitonin 2% (v/v), 10 |iM Na-orthovanadate, 10 |ig/ml leupeptin, 10 pg/ml 
aprotinin) . Subsequently the CD4 receptor was immunoprecipitated as described in
2.5.5 using 2 |ig of the HP2/6 anti-CD4 antibody. The samples were then analysed by 
western bloting using an antibody against p56'"’' (1.5.1) as this kinase is constantly 
associated to the CD4 receptor. As shown in figure III.23 p56'^‘' association was readily 
detected in Triton X-100 lysed samples even at low concentrations of detergent (lanes 
A,B,C). A weaker signal was detected in Brij58 treated samples (lane F) while much 
lower amounts of p56'"'' were detected in digitonin treated samples (lanes D, E).
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Therefore, for further experiments a 1% Triton X-100 containing lysis buffer was used 
(II. 1.2).
Fig. III.23: Optimization of CD4 immunoprécipitation. p56 Ick
expression in unstimulated HPBALL cells lysed in a buffer containing 
either Triton X-100 (A-C) at various concentrations 1% (A), 0.5 % (B), 0.1 
% (C), or digitonin at 2%(D) and 1 %(E), or Brij58 1% (F) and 
immunoprecipitated using an aCD4 antibody. (G) p56'^’‘ expression in 
HPBALL whole cell lysate.
5.2 Lack of recruitment of signaling molecules to the CD4 receptor complex during 
apoptosis
In order to investigate the recruitment of signaling molecules to the CD4 
receptor upon induction of apoptosis HPBALL cells were metabollically labelled as 
described in II.2.5.4. Apoptosis was then induced by incubating 2x10’cells per sample 
in the absence or presence of aCD4 and then tranferring them to previously coated 12 
well plates (see II.2.3.9) at 2x10^ cells per well for the indicated time points (fig. III.24). 
The cells were then collected and CD4 was immunoprecipitated in unstimulated and 
stimulated cells as described in II.2.5.5. The samples were then analysed by one 
dimensional gel electrophoresis (see II.2.5.4).
As shown in figure III.24 no differences in the CD4 receptor complex 
composition were seen between unstimulated (lanes A,B) or CD4 stimulated cells (C-H) 
at the various time points tested after a seven day exposure of the film. Similar results 
were obtained after a twenty one day exposure of the film. This finding suggests lack of 
recruitment of signaling molecules to the CD4 receptor complex during apoptosis 
induction.
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Fig. III.24: Lack of recruitment of signaling molecules to the CD4 
receptor complex during apoptosis. Unstimulated (A, B) or CD4
stimulated for 5 min (C, D), 10 min (E, F) or 30 min (G, H) labelled 
HPBALL cells were immunoprecipitated with either protein A IgG coupled 
control beads (A, C, E, G) or protein G beads/ 2 jig anti-CD4 (HP2/6) (B) 
or protein G beads alone (D, F, H). A seven day exposure of the film is 
shown.
5.3 Tyrosine Phosphorylation of signaling molecules is not involved in aCD4 
induced apoptosis
Since signaling molecules did not seem to be recruited to the CD4 receptor complex 
upon apoptosis induction the role of phosphorylation was examined.
5.3.1 Lack of Tyrosine phosphorylation of signaling molecules after induction of 
CD4 mediated apoptosis
HPBALL cells were incubated in the presence or absence of aCD4 as previously 
described (II.2.3.9). In order to compare phosphorylation events following an apoptotie 
or a nonapoptotic stimulus, however, the CD4 antibody was further crosslinked by 
either coated (apoptotie stimulus) or soluble (nonapoptotic stimulus) secondary
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antibody. The samples were incubated in the presence of either coated or soluble 
crosslinking antibody for the indicated time points (figure 111.25).
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Fig. III. 25 : Lack of Tyrosine phosphorylation of signaling molecules 
after induction of CD4 mediated apoptosis. Immunoblotting with an anti- 
phosphotyrosine Ab (PY99) of 10^  HPBALL cells either left untreated 
(lanes 1, 6) or stimulated via aCD4+soluble secondary Ab (lanes 2-5) or 
aCD4+coated secondary Ab (lanes 7-10) for 1 min (lanes 2, 7), 5 min 
(lanes 3, 8), 10 min (lanes 4, 9) and 30 min (lanes 5, 10). One representative 
experiment of five is shown.
Cell lysates were subsequently prepared as described in II.2.5.1 and analysed by 
immunoblotting with an anti-phosphotyrosine antibody.
As shown in figure III.25 stimulation of the CD4 receptor by a nonapoptotic 
stimulus (lanes 1-5) lead to phosphorylation of the adaptor molecules c-Cbl and LAT, 
the protein tyrosine kinase ZAP-70 and a nonidentified 23 kDa protein, already 1 min
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after stimulation. In contrast no specific phosphorylation events were observed after 
induction of aCD4 induced apoptosis (lanes 6-10).
5.3.2 PP2 does not inhibit aCD4 induced apoptosis
In order to verify that aCD4 induced apoptosis is independent of tyrosine 
phosphorylation the tyrosine kinase inhibitor PP2 was used. 10^  HPBALL cells were 
incubated for 40 min in the absence or presence of various concentrations of PP2. 
Apoptosis via CD4 was then induced as previously described (II.2.3.9) and measured 
after 2 h by the PI uptake assay and flow cytometry.
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Fig. III.26: PP2 does not inhibit aCD4 induced apoptosis. Specific 
apoptosis of unstimulated (white squares) or aCD4 stimulated (black 
squares) HPBALL cells in the presence of various concentrations of PP2 
(pM). One representative experiment of three done in triplicates is shown.
PP2 was slightly toxic at high concentrations (7.7 % specific cell death at 20 pM) 
while no toxicity was observed at concentrations up to 5 pM (figure 111.26). PP2 failed 
to inhibit aCD4 induced apoptosis at all concentrations tested. This further suggested
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that the mechanism of aCD4 induced apoptosis does not involve tyrosine 
phosphorylation of signaling molecules.
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Role of mitochondria and AIF in aCD4 induced apoptosis
The novel type of caspase independent CD4 and CXCR4 mediated cell death 
was found to be accompanied by loss of the inner mitochondrial transmembrane 
potential (A'Fm) (Bemdt et al., 1998) which is a result of mitochondrial membrane 
permeabilisation (MMP). In certain cell types this event is a prerequisite for apoptosis 
induction. Since mitochondria were also found to be involved in CD4/CXCR4 mediated 
cell death in PBLs from HIV-1 infected individuals (chapter 2), their role was examined 
in more depth in the cell line system, focusing on aCD4 induced apoptosis. Moreover, 
the role of the recently discovered apoptosis inducing factor (AIF) which has been 
implicated in the induction of caspase independent apoptosis was investigated.
6.1 Mitochondrial transmembrane potential reduction (AYm) during aCD4 
induced apoptosis is caspase independent
In order to assess whether A'Fm is a caspase independent event during aCD4 
induced apoptosis and thus not due to secondary unspecific effects the pancaspase 
inhibitor zVAD-fmk was used. This tripeptide broad spectmm caspase inhibitor acts 
like the closely related inhibitor BD-fmk (see 111.2.2.1). HPBALL cells were 
preincubated for 40 min in the absence or presence of zVAD-fmk. Apoptosis was then 
induced via CD4 as previously described and AYm was assessed via DiOC^(3) staining 
(see II.2.3.7) at the indicated time points (fig.III.27).
As shown in figure 111.27 the transmembrane mitochondrial potential was 
reduced during aCD4 induced apoptosis (A) approximately 30 min after stimulation 
(B). A'Pm was not inhibited by zVAD-fmk at any of the time points tested (B).
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Fig. III.27: AYm during aCD4 induced apoptosis is not inhibited by 
ZVAD-fmk. (A) Mitochondrial transmembrane potential, evaluated by 
DiOCg(3) staining (FL-1), is reduced in aCD4 treated (thick line histogram) 
compared to untreated (thin line histogram) HPBALL cells. (B) Percentages 
of HPBALL cells with reduced mitochondrial transmembrane potential after 
stimulation with aCD4, in the absence (white bars) or presence (grey bars) 
of 50 pM zVAD-fmk, for the indicated time points. One representative 
experiment of three done in triplicates is shown.
6.2 Cytochrome C is released during aCD4 induced apoptosis
Since MMP also results in translocation of cytochrome c (Cyt-C) from the 
mitochondrial intermembrane space to the cytosol (Green and Reed, 1998) Cyt-C 
localisation was assessed during aCD4 induced apoptosis of HPBALL cells.
CD4 mediated apoptosis was induced as previously described and the samples 
were then subjected to subcellular fractionation (see 11.2.3.8). Cyt-C translocation was 
then assessed by immunoblotting 1 h after stimulation via aCD4.
As shown in figure III.28A Cyt-C could be seen in the cytosol of untreated cells 
reflecting the relatively high background apoptosis in these samples (approximately 15 
% apoptosis) (lane 1). Upon stimulation via CD4, however, the amount of Cyt-C 
significantly increased in the cytosolic fraction (compare lanes 1 and 3) reflecting
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specific Cyt-C release during aCD4 induced apoptosis. A similar pattern of Cyt-C 
translocation was seen when the samples were preincubated with the caspase inhibitor 
zVAD-fmk (fig. 28B). This verified that MMP proceeds in a caspase-independent 
fashion during CD4 mediated cell death.
B
Fig. III.28 : Cytochrome C translocation during aCD4 induced 
apoptosis. Cytochrome C localisation in cytosolic (lanes 1, 3) or 
mitochondrial (lanes 2, 4) fractions of aCD4 treated (lanes 3, 4) or untreated 
(lanes 1, 2) HPBALL cells in the absence (A) or presence (B) of 50 pM 
ZVAD-fmk.
6.3 AIF tranlocation during aCD4 induced apoptosis
In addition to Cyt-C, the flavoprotein oxidoreductase apoptosis inducing factor 
(AIF) has been shown to translocate to the cytosol and nucleus thereby stimulating 
apoptosis via an as yet unknown caspase-independent mechanism (Susin et al., 1999). 
AIF translocation was evaluated during aCD4 induced apoptosis by intracellular 
immunofluorescence staining (see II.2.2.3.2). HPBALL cells were incubated in the 
presence or absence of aCD4 and apoptosis was induced as previously described. After 
a 2 h incubation the cells were stained with antibodies against AIF and the 
mitochondrial matrix protein Hsp60 (which does not translocate during apoptosis) as 
well as with Hoechst 33342 (a DNA intercalating dye). The samples were then analysed 
by confocal microscopy.
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Fig. III.29 : AIF tranlocation during aCD4 induced apoptosis. Untreated 
(A) or aCD4 treated (B) HPBALL cells were stained with anti-AIF (red 
fluorescence), anti-Hsp60 (green fluorescence) and Hoechst 33342 (blue 
fluorescence). AIF colocalises with Hsp60 to the mitochondria (punctate 
yellow fluorescence) in untreated cells (A), while it translocates to the 
nucleus and cytosol upon stimulation via CD4 (purple nuclear fluorescence 
and red fluorescence in the cytosol) (B).
As shown in figure III.29A AIF and Hsp60 were colocalised (yellow punctate 
fluorescence, blend of green plus red) in control untreated cells. In contrast diffuse red 
cytoplasmic fluorescence and purple nuclear fluorescence (blend of red plus blue), 
indicative of the AIF translocation, were observed in anti-CD4 stimulated cells.
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6.4 Large scale DNA fragmentation occurs in aCD4 treated HPBALL cells
AIF translocation to the nucleus correlates with the appearance of large scale 
DNA fragmentation. Since AIF was found to translocate to the nucleus during aCD4 
induced apoptosis the formation of large DNA fragments was investigated. CD4 
mediated apoptosis was induced as previously described and large scale DNA 
fragmentation was assessed 3 h or 10 h following stimulation, via pulse field gel 
electrophoresis (see II.2.3.6).
As shown in figure III.30 large DNA fragmentation (approximately 50 Kb) was 
readily seen in aCD4 treated cells at both time points tested (lanes B and E). However, 
when the aCD4 treated cells were preincubated in the presence of the pancaspase 
inhibitor zVAD-fmk large DNA fragmentation was almost completely inhibited (lanes 
C and F). Since aCD4 induced apoptosis proceeds in a caspase independent manner this 
finding suggests that large DNA fragmentation is probably a secondary effect.
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Fig. 111.30: Large scale DNA fragmentation occurs in antiCD4 treated HPBALL 
cells. DNA fragmention pattern of HPBALL cells incubated for 3 h (lanes A, B, C) or 
10 h (lanes D, E, F) in the absence (A and D) or presence of either aCD4 (lanes B and 
E) or aCD4 plus 50 pM ZVAD-fmk (lanes C and F).
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IV DISCUSSION
aCD4/aCXCR4 induced apoptosis in PBLs from HIV-1 infected 
individuals
Patients infected with HIV-1 experience a progressive decline in CD4 T-cell 
number which leads to immunodeficiency and increased susceptibility to opportunistic 
infections and malignancies. Although CD4 T-cell production is impaired in HIV-1 
infected patients (Hellerstein et al., 1999), the primary basis of T-cell depletion has been 
shown to be increased apoptosis of CD4 and CDS T cells (Gougeon et al., 1996; Badley 
et al., 2000). Since only a minor fraction of apoptotie lymphocytes are physically 
infected by HIV-1 (Ameisen et al., 1995), cytopathic effects of the virus due to direct 
infection cannot solely account for the enhanced apoptosis of lymphocytes seen in 
infected persons. This indicates that other indirect mechanism(s) are involved.
Indeed, several studies have demonstrated that the HIV-1 envelope glycoprotein 
gpl20, either in membrane bound or soluble form, can induce apoptosis of both infected 
and non-infected bystander T cells (Laurent-Crawford et al., 1993; Finkel et al., 1995; 
Banda et al., 1992). Moreover crosslinking of the CD4 receptor by monoclonal 
antibodies, thus mimicking the CD4-gpl20 interaction, induces apoptosis in 
lymphocytes from HIV-1 infected individuals (Oyaizu et al., 1993). Further studies by 
Westendorp et al. on the mechanism of gpl20 induced apoptosis demonstrated that in 
non-infected lymphocytes this was partly dependent on the CD95 death system. Recent 
studies, however, showed that stimulation of the CD4 receptor and the CXCR4 
chemokine coreceptor by gpl20 or monoclonal antibodies could also lead to a novel 
type of CD95 independent cell death (Bemdt et al., 1998).
In this work, the role of CD4 and CXCR4 induced apoptosis as a potential 
indirect mechanism of T-cell depletion during HIV-1 infection was investigated. 
Moreover the relative contribution of the previously described cell death pathways
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engaged by these receptors during apoptosis induction was assessed in the in vivo 
situation. For the induction of apoptosis and in order to be able to dissect the signals via 
the two receptors specific antibodies against CD4 and CXCR4 were used recognising 
the same epitopes as gpl20. It was shown that freshly isolated PBLs from a 
representative cohort of 202 HIV-1 infected individuals exhibited a significantly higher 
sensitivity to CD4 and CXCR4 mediated apoptosis compared to PBLs from healthy 
control subjects. Based on these findings the question arises: what does CD4 and 
CXCR4 mediated cell death represent in the context of HIV-1 infection?
In the context of antigen presentation, antigenic stimulation of lymphocytes in 
the absence of a costimulatory signal leads to either anergy, in the case of resting cells, 
or to activation induced cell death, in the case of preactivated cells (Russel et al., 1991; 
Dhein et al., 1995; Alderson et al., 1995; Miethke et al., 1996). Normally stimulation of 
the CD4 receptor enhances activation and proliferation that ensues after T-cell receptor 
(TCR) engagement while stimulation of the CD4 receptor alone (in the absence of TCR 
engagement) can lead to induction of activation induced apoptosis of preactivated 
lymphocytes (Algeciras et al., 1998). The same phenomenon has also been described 
following stimulation of the TCR alone (Dhein et al., 1995); the B-cell receptor (Chan 
et al., 1990), the MHC-1 molecule (Wallen-Ohman et al., 1997; Nilsson et al., 1997), the 
MHC-11 molecule (Truman et al., 1994) as well as the CD2 receptor (Wesselborg et al., 
1993; Rouleau et al., 1993).
A general state of immune activation is rapidly observed in the asymptomatic 
phase of HIV-1 infection in both lymphoid tissue and peripheral blood lymphocytes and 
persists throughout the course of HIV-1 disease. This is reflected by follicular 
hyperplasia and expression of activation markers, such as CD45RO in the lymph nodes 
(Muro-Cacho et al., 1995; Bofill et al., 1995) and in the peripheral blood (Giorgi et al., 
1993; Levacher et al., 1992). The degree of lymphocyte apoptosis in lymph nodes from 
HIV-1 infected patients has been shown to correlate with the state of activation of the 
lymphoid tissue (Muro-Cacho et al., 1995). Moreover, Gougeon et al. have shown that 
CD45RO+ activated cells are expanded in vivo in HlV-1 infected patients and are more 
prone to apoptosis compared to the same subset in control subjects.
Discussion 105
Therefore, the increased aCD4 induced apoptosis seen in PBLs from HlV-1 
infected individuals, in the present experimental system, probably represents a form of 
activation induced cell death due to the hyperactivation of lymphocytes during the 
course of the infection. This is further supported by the data obtained with PBLs from 
healthy individuals where preactivation rendered the cells susceptible to CD4 mediated 
apoptosis. Subset analysis of these PBLs also showed that CD45RO+, activated, cells 
were sensitive to CD4 induced apoptosis in contrast to CD45RA+ cells.
In the present system apoptosis was induced via monoclonal antibodies while, in 
the context of HlV-1 infection circulating immune complexes and replication- 
incompetent viruses that contain gpl20 could induce death in a similar manner 
(Kameoka et al., 1997; Ellaurie et al., 1990; Aceituno et al., 1997). Moreover, during 
HlV-1 infection there is an increase of anti-CD4 antibodies (Keay et al.,1995; Muller et 
al., 1994; Burastero et al., 1996) and more importantly of soluble gpl20 (Oh et 
al.,1992), anti-gpl20 antibodies (Ellaurie et al., 1990; Feijoo et al., 1995) and a large 
number of defective virions (Wie et al., 1995; Ho et al., 1995), all of which can lead to a 
chronic and significant degree of CD4 activation and subsequent cell death in 
uninfected CD4+ cells.
In the case of CXCR4 mediated apoptosis a similar scenario could be envisaged. 
During the course of HIV-1 infection CCR5-using (R5) viruses represent the 
predominant virus population early after infection while CXCR4-using (X4) viruses 
and/or viruses with dual tropism emerge later in disease in temporal association with 
rapid CD4+ T cell decline and progression to AIDS (Connor et al., 1997; Scarlatti et al., 
1997; Schuitemaker et al., 1992; Xiao et al., 1998). In fact recent studies have shown 
that HIV-1 envelope specificity for CXCR4 is linked to aggressive depletion of the 
CD4+ T-cell population in ex vivo human lymphoid histocultures and PBMC 
suspensions (Penn et al., 1999; Schramm et al., 2000). These findings support the 
hypothesis that the evolution of viral envelope leading to usage of CXCR4 in vivo 
accelerates loss of CD4+ T cells causing immunodeficiency. It is therefore probable that 
ligation of CXCR4 in the surface of hyperactivated CD4+ lymphocytes by soluble or
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membrane bound gp l20 leads to apoptosis in the later stages of HlV-1 infection. As for 
CD4 mediated apoptosis, this is further supported by the fact that activated CD45RO+ 
cells from healthy subjects were susceptible to aCXCR4 induced apoptosis in contrast 
to naive CD45RA+ cells. Moreover CXCR4 was predominantly expressed in 
CD45RO+ cells which probably accounted for their apoptosis sensitivity.
The findings of this work could have important implications in the development 
of therapeutic strategies for HlV-1 infection. In view of the critical role of CCR5 and 
CXCR4 in HIV infection the search and development of blocking agents against these 
two receptors have been the focus of intensive research. One approach which has been 
suggested in order to achieve selective blockade of these receptors is the use of 
monoclonal antibodies. In fact, monoclonal antibodies have been used as effective 
inhibitors of both chemokine and HIV binding in the case of the CCR3 and CCR5 
receptors (Heath et al., 1997; Wu et al., 1997; Grimaldi et al., 1999). However, as the 
present work shows, antibodies against CXCR4, specific for HIV-1 binding epitopes, 
could induce cell death and thus may have detrimental effects on the patients.
Therefore, the most promising approach for selective chemokine receptor 
blockade is represented by small organic molecules. A number of small molecule 
antagonists have been already identified that are selective for CXCR4 such as 
AMD3100 (Schols et al., 1997), T22 (Murakami et al., 1997) and ALX40-4C (Doranz 
et al., 1997). A recent study suggested that ALX40-4C could be safely used in phase I/II 
clinical trials although more sophisticated measures of viral phenotype were needed to 
accurately assess its effects (Doranz et al., 2001).
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Correlation of CD4/CXCR4 mediated apoptosis with virological 
features and therapy
Apoptosis induction via CD4 and CXCR4 did not correlate with the plasma 
viral load, CD4 positive cell counts or stage of the disease of the patients in the overall 
group of patients tested. Interestingly, however, in patients which did not receive any 
treatment (therapy naïve), high rates of apoptosis correlated with high viral load and 
inversely correlated with CD4 counts. This finding further supports the hypothesis that 
gpl20 induces CD4/CXCR4 mediated apoptosis in vivo and that this apoptosis plays a 
role in the pathophysiology of HlV-1 infection, by contributing to the depletion of 
CD4+ T cells.
Another issue raised, by the findings of this work, is the effect of therapy on 
CD4 and CXCR4 mediated apoptosis. The introduction of combination therapy has led 
to an overall drop in mortality and illness due to HIV-1. The HIV protease inhibitors 
decrease viral replication and hence plasma viral RNA levels resulting in a sustained 
increase in CD4 positive T cells. Several studies have shown that apoptosis in lymph 
nodes, rectal mucosa and PEL subsets from patients infected with HlV-1 decreases 
dramatically in response to protease inhibitor based HlV-1 treatment (Badley et al., 
1999; Chavan et al., 1999; Bohler et al., 1999; Johnson et al., 1998; Kotler et al., 1998). 
This effect was seen for spontaneous apoptosis, AlCD, apoptosis due to mitogenic 
stimulation and CD95 receptor ligation (Johnson et al., 1998; Aries et al., 1998; Bohler 
et al., 1999). The data presented in this thesis further support these findings, as HAART 
initiation led to a significant reduction in CD4/CXCR4 induced apoptosis of PBLs from 
HIV-1 infected patients, independently of plasma viraemia. It has been previously 
suggested that protease inhibitors might exert their antiapoptotic function by directly 
inhibiting caspases (Sloand et al., 2000; Phenix et al., 2000; Weichold et al., 1999). 
However, recent studies suggest that protease inhibitors may be blocking cell-cycle 
progression and proteosomal activity in lymphocytes (Chavan et al., 2001; Schmidtke et 
al., 1999). The predominant apoptotie pathway, engaged during CD4/CXCR4 mediated 
apoptosis, is caspase independent. This further supports the notion that protease 
inhibitors may not exert their function by inhibiting caspases.
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Multiple cell death pathways are engaged by the CD4 and CXCR4 
receptors in PBLs from HIV-1 infected individuals
Since PBLs from HlV-1 infected individuals were sensitive to CD4/CXCR4 
mediated cell death it was subsequently investigated whether this phenomenon 
corresponded to the novel type of apoptotie death previously described to be triggered 
by these receptors. Initial experiments showed that aCD4 and aCXCR4 induced 
apoptosis exhibited different kinetics in PBLs from HlV-1 infected individuals than 
what had been described in cell lines. Thus, maximal apoptosis induction was observed 
after 18h in PBLs from HlV-1 infected individuals, compared to 2 h in the cell line 
system. Different kinetics could reflect engagement of different pathways of cell death 
induction. Alternatively, this could be due to physiological differences between 
malignant and primary cells such as different stage of activation or sensitization 
threshold.
In order to gain more insight into the cell death pathways possibly engaged by 
the CD4 and CXCR4 receptors during apoptosis induction, in the in vivo situation, the 
role of the CD95, TNF and TRAIL systems was assessed. Inhibition of either the CD95 
or TNF death systems did not significantly block CD4 and CXCR4 mediated apoptosis 
in the overall subgroup of patients tested. This is consistent with other studies showing a 
lack of dependence of HIV-1 induced CD4^ T-cell apoptosis on the CD95 system 
(Gandhi et al., 1998; Noraz et al., 1997). These findings contradict, however, the studies 
by Herbein et al. who showed that HIV-1 gpl20-CXCR4 interactions triggered T cell 
death by macrophage production of TNF. In the present system no inhibition of 
CD4/CXCR4 induced apoptosis was seen by agents blocking the TNF system both in 
the presence or absence of monocytes.
A partial inhibition of apoptosis was seen by blockage of the TRAIL system. 
Although the physiological role of the TRAIL receptors remains elusive, previous 
studies have suggested a role for the TRAIL system in apoptosis in HIV-1 infected 
patients. T cells from HlV-1 infected patients showed susceptibility to TRAIL mediated 
apoptosis compared to T cells from healthy control subjects (Jeremias et al., 1998) and
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AICD of PBLs from HlV-1 positive individuals could be partially inhibited by TRAIL- 
specific antagonistic antibodies (Katsikis et ah, 1997). The data presented here would 
further support a role for the TRAIL system in lymphocyte apoptosis during HIV-1 
infection, although in the present system this does not represent the principal cell death 
pathway engaged by the CD4 and CXCR4 receptors. TRAIL induced apoptosis is 
dependent on caspases. However, in the present system, aCD4/aCXCR4 induced 
apoptosis could be partially inhibited by inhibitors of the TRAIL system in some 
patients but not necessarily with caspase inhibitors in the same patients. This would 
suggest that TRAIL receptor mediated apoptosis can proceed independently of caspases, 
but it most probably reflects technical limitations of the assays, due to low percentages 
of apoptosis induction via CD4 and CXCR4 and low percentages of inhibition via the 
TRAIL system and caspase inhibitors.
Interestingly, the patients that exhibited a partially TRAIL dependent PBL 
apoptosis had a high viral load . This suggests that different quantitative requirements 
for gpl20 might determine the engagement of different apoptotie pathways.
In order to investigate the role of caspases in CD4/CXCR4 induced apoptosis in 
HIV-1 infected individuals the broad spectrum, irreversible caspase inhibitor BD-fmk 
was used. Indeed, in the majority of the patients no inhibition of apoptosis was seen, 
thus indicating a caspase independent mechanism of apoptosis induction. That was 
further confirmed by the lack of caspase-8 and PARP cleavage in PBL lysates from 
patients where apoptosis was not BD-fmk inhibitable. However, in some individuals a 
partial inhibition via BD-fmk was observed. The inhibition pattern showed great 
variability within the experimental group. These data suggest that multiple pathways of 
apoptosis can be engaged by CD4 and CXCR4 in primary cells from HlV-1 infected 
individuals. As far as CD4 is concerned, this is in agreement with previous findings by 
Westendorp et al. where CD4 induced apoptosis in primary T cells was partially 
mediated by a caspase dependent mechanism (Westendorp et al., 1995). Recently, 
triggering of CXCR4 by either cell surface HlY-1 envelope, soluble primary gpl20 or 
anti-CXCR4 antibodies, in an ex vivo infection system, has been demonstrated to induce 
apoptosis in infected and uninfected primary T cells independently of caspases
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(Vlahakis et al., 2001). However, this system might not accurately represent the in vivo 
situation which appears more complex. The data presented in this study suggest that 
CXCR4 mainly engages a caspase independent pathway of cell death induction but that 
it also engages a caspase dependent one, albeit to a lesser degree.
Mitochondria have been shown to play a major role in apoptosis triggered by 
many stimuli. Since mitochondria were shown to be involved in CD4/CXCR4 induced 
apoptosis in the cell line systems their involvement was also assessed during 
CD4/CXCR4 induced apoptosis in PBLs from HIV-1 infected patients. Cytochrome c 
release which results from mitochondrial membrane permeabilisation was seen in 
CD4/CXCR4 stimulated lymphocytes. However, in this experimental setup it was not 
possible to define whether cytochrome c release corresponded to the caspase dependent 
or independent component of CD4/CXCR4 induced apoptosis. The role of mitochondria 
and cytochrome c release was more extensively examined in the cell line system and 
will be discussed in further detail in this context.
Another intriguing finding was that no DNA fragmentation, a hallmark of 
classical apoptosis was seen during CD4/CXCR4 mediated apoptosis. This is in 
accordance to data obtained in the HPBALL cell line system where no 
oligonucleosomal DNA fragments were detected during CD4/CXCR4 mediated 
apoptosis. As previously suggested DNA fragmentation may not be essential for 
cellular destruction since cytoplasts (cells without nuclei) can undergo apoptotie cell 
death (Jacobson et al., 1994; Schulze-Osthoff et al., 1994; Nakajima et al., 1995). 
However, this result should be cautiously interpreted as it could be due to lack of 
sensitivity of the Nicoletti assay considering the low levels of specific aCD4/aCXCR4 
induced apoptosis in PBLs from HlV-1 infected individuals.
Prior to oligonucleosomal DNA fragmentation, large scale DNA fragmentation 
generating 50 kb fragments also occurs during apoptotie cell death (Wyllie et al., 1980). 
In fact, in certain systems such as in glucocorticoid induced apoptosis of thymocytes 
only 50 kb DNA fragments can be detected (Walker et al., 1993). Although large scale 
DNA fragmentation was not investigated during CD4/CXCR4 mediated apoptosis, in
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PBLs from HIV-1 infected individuals, it is probably also not prerequisite for apoptosis 
induction as shown by experiments in the HPBALL cell line system which will be 
discussed further on.
Therefore, the findings of this study suggest that the in vivo situation is rather 
complex since multiple cell death pathways seem to be engaged by the CD4 and 
CXCR4 receptors. Nevertheless, the novel CD95 and caspase independent death 
pathway seems to be predominantly involved in this phenomenon. The molecular 
mechanism of this novel pathway was subsequently investigated in cell line systems.
Investigation of the mechanism of CXCR4 mediated apoptosis in a cell 
line system
In order to identify regions in CXCR4 required for the transmission of the 
apoptotie signal the ability of chimeras based on CXCR4 and CXCR2 to mediate 
apoptosis was examined. These receptors share approximately 35% amino acid identity 
but CXCR2 does not act as a coreceptor for HIV-1. In order to ensure that the apoptotie 
activity of the chimeric receptors is solely due to the CXCR4 component apoptosis 
induction was assessed in BJAB cells stably expressing the CXCR2 receptor and 
stimulated with a monoclonal antibody recognising the amino terminal domain of the 
receptor. No apoptosis induction was seen following stimulation of the CXCR2 receptor 
according to the same experimental protocol as for the CXCR4 receptor. However, one 
cannot exclude that the CXCR2 molecule can potentially mediate apoptosis upon 
stimulation via antibodies recognising different epitopes.
Nevertheless, based on this approach it was shown that the carboxy terminal 
domain of CXCR4 was dispensable for apoptosis induction since chimera 4442 and the 
mutant CXCR4 Acyto could mediate apoptosis at levels comparable to the wild type 
receptor (see figure 111.17 for schematic representation of chimeric receptors). This 
indicated that the 18 serine/threonine residues of this domain, which represent potential 
targets for phosphorylation by G protein-coupled receptor kinases, second messenger-
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activated protein kinases and PKC (Freedman and Lefkowitz, 1996) are not involved in 
this apoptotie pathway. This region of CXCR4 has been implicated in CXCR4 
desensitisation and internalisation of the receptor. Deletion of this domain did not affect 
HIV fusion and entry but prevented the downregulation of the receptor following 
stimulation via SDFl (Amara et al., 1997).
The third extracellular loop and seventh transmembrane domain were also 
dispensable for the apoptotie function of the CXCR4 receptor (chimera 4442). The third 
extracellular loop has been implicated in the formation and maintenance of a 
conformation that is permissive for vims interaction although the first and second 
extracellular loops are the ones critically required for coreceptor activity (Lu et al., 
1997). The amino terminal region of CXCR4 (chimera 2444) also did not play a role in 
apoptosis induction. This was expected as this domain contains the binding site for the 
natural CXCR4 ligand SDFl (Cmmp et al., 1997) which was not found to induce 
apoptosis in the HPBALL and BJAB cell lines but rather downregulation of the 
receptor.
Replacement of both the aminoterminal and the region containing the sixth 
transmembrane domain, third extracellular loop, seventh transmembrane domain and 
carboxyl terminal (chimera 2442) was also tolerated for apoptosis induction. This 
indicated that the region from aa 28 till the sixth transmembrane domain was potentially 
critical for apoptosis induction.
Further replacement of the region of CXCR4 from the amino terminal till the 
second intracellular loop led to loss of the apoptotie function (chimera 2244) indicating 
that the first and second intracellular loops are critical for apoptosis induction. The 
second intracellular loop of CXCR4 contains a DRY amino acid motif which in related 
receptors plays an important role in G protein coupling (including CCR5) (Lu et al., 
1997). Although CXCR4 induced apoptosis was not mediated via the GTPase G^a, 
other G proteins like Ga^ or Ga,^ which have been recently implicated in cell death 
signaling (Maghazachi, 1997) could play a role in apoptosis induction. Point mutations 
of this motif and analysis of apoptosis induction will further elucidate its role in cell 
death signaling.
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However the results obtained with the 2244 chimeric receptors should be 
cautiously interpreted. The 12G5 monoclonal antibody against CXCR4 used to induce 
apoptosis is conformation dependent and its epitope is contained in extracellular loops 
one and two. Since extracellular loop one is replaced in 2244, 12G5 fails to bind to the 
chimeric receptor. Therefore the aCXCR2 antibody 10G2 was used for apoptosis 
induction via this receptor. The inability of the receptor to transmit the apoptotie signal 
could reflect stimulation via an inappropriate epitope. Moreover, chimera 2244 was 
expressed at lower levels on the surface of BJAB cells compared to the wild type 
receptor which could also explain reduced apoptosis induction.
In general, while much information can be gained by using chimeric receptors 
the relative importance of specific residues or regions may be masked because of the 
similarity between the two parental molecules. Moreover, for future studies a slightly 
different approach could be followed by using receptors where only intracellular parts 
are exchanged thus retaining the epitope for the apoptotie stimulus.
Investigation of the mechanism of CD4 mediated apoptosis in cell line 
systems
In order to gain some insight into the mechanism of the novel type of aCD4 
induced cell death a structure-function study approach was also followed. BJAB cells 
expressing truncated forms of CD4 were examined (see figure III.20 for schematic 
representation of CD4 mutants).
Cells expressing the 431 mutant, lacking two hydrophobic amino acids at the 
carboxy terminal, were sensitive to aCD4 induced apoptosis. This CD4 mutant has been 
recently described to confer a gain of function phenotype in antigen dependent T cell 
activation. Moreover this mutation abolished the binding of the novel CD4 associated 
protein ACP33 to CD4 (Zeitlmann et al., 2001). Although ACP33 has been suggested to 
actively transduce an inhibitory signal and therefore act as a negative regulatory factor 
in CD4 dependent T cell activation, it does not seem to play a role in aCD4 induced
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apoptosis. Experiments with the 429 mutant receptor gave similar results as with the 
431 receptor indicating that the carboxy terminal proximal region of the receptor is not 
necessary for apoptosis induction.
The 419 mutant lacks the dicysteine motif (aa 420-422) which harbors the 
p561ck binding site. Although BJAB cells do not express p56^ ^^  this mutant, as well as 
the p561ck- one, were examined for apoptosis sensitivity as the dicysteine motif could 
be important for the binding of other B cell expressed src kinases, which could 
substitute for p56^ ^^ . Moreover, the association of the adaptor molecule LAT to CD4 has 
been shown to be promoted by this cysteine motif (Bosselut et al., 1999) which may 
also be important for B cell expressed adaptor molecules. However, cells expressing the 
419 and p561ck- mutants retained sensitivity to aCD4 induced apoptosis thus indicating 
that this motif is not implicated in the apoptotie signaling.
Expression of the 411 mutant receptor showed that the dileucine motif found in 
amino acids 413-414 which has been implicated in CD4 signaling was also not involved 
in the apoptotie pathway (Moutouh et al., 1998). Moreover, the short a  helix between 
aa 409 and 414 which mediates binding of the multimeric adaptor proteins AP-2 and 
AP-1 was also dispensable for the apoptotie function (Pitcher et al., 1999). These 
adaptor molecules have been implicated in termination of cell surface receptor signaling 
and regulation of receptor internalisation (Clements et al., 1999)
Interestingly, apoptosis induction was reduced but not abrogated when the 398 
CD4 mutant, lacking the whole cytoplasmic tail, was expressed. This suggested that the 
cytoplasmic tail of CD4 was dispensable for apoptosis induction although the region 
from aa 411 to 398, may be implicated in the magnitude of the apoptotie signal.
These results are in agreement with previous studies by Guillerm et al. who found 
delayed HIV-1 induced apoptosis in cells expressing truncated forms of the CD4 
receptor (at aa 401 or 403). This was further supported by the work of Jacotot and 
coworkers who also reported that A2.01 cells expressing a CD4 mutant receptor 
truncated at aa 402 underwent apoptosis induced by HIV-1 infection or by coculture 
with chronically HIV-1 infected H9 cells.
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It has also been shown that surface expression of tailless CD4 at high levels is 
able to circumvent the T cell development requirement for signal transduction by the 
cytoplasmic domain of CD4 (Killeen and Littman, 1993). However, in the present 
system, this could not account for the transduction of the apoptotic signal since the 398 
receptor was expressed at comparable levels as the wild type CD4.
Further evidence supporting a lack of requirement of the CD4 cytoplasmic tail in 
aCD4 induced apoptotic signaling was obtained via biochemical analysis of the 
receptor in the T cell line HPBALL. These data suggested lack of recruitment of 
signaling molecules to the CD4 receptor complex upon apoptosis induction in 
metabolically labelled cells. However, this result should be cautiously interpreted as 
there are some technical pitfalls. Since cellular proteins have variable half lifes one 
cannot exclude that certain signaling molecules may not be metabolically labelled 
during the 24 h incubation with [^ S^] labelled amino acids. Thus, these molecules would 
not be detected in the experimental set-up used. Moreover, since apoptosis induction 
requires crosslinking of the aCD4 antibody by a secondary plate bound antibody, it 
remains unclear to what extend the stimulated CD4 receptor is immunoprecipitated or 
stays bound to the crosslinking antibody.
Interestingly, however, a quite prominent band of approximately 35 kDa 
appeared in the unstimulated CD4 receptor complex while it was not detected upon 
stimulation of the receptor. Whether this represents a negative regulatory factor which is 
released upon apoptosis induction thus activating downstream signaling molecules 
needs to be elucidated in future work.
Further biochemical analysis of tyrosine phosphorylation of signaling molecules 
showed that stimulation of the CD4 receptor via a non-apoptotic stimulus led to 
phosphorylation of the adaptor molecules LAT and c-Cbl and the protein tyrosine 
kinase ZAP-70. This is in agreement with other studies where all three molecules have 
been shown to be phosphorylated upon CD3 or CD4 ligation (van Leeuwen et ah, 1999; 
Murphy et al., 1998). Moreover Cbl has been previously shown to have a negative 
regulatory role during TCR signaling supporting the notion that CD4 ligation alone 
leads to negative signaling promoting anergy rather than activation. In contrast, 
stimulation of the CD4 receptor via an apoptotic stimulus did not lead to particular
Discussion______________________________  116
phosphorylation events. However, only tyrosine phosphorylation events were examined 
so it remains to be tested whether there is a role for threonine phosphorylation in the 
transduction of the apoptotic stimulus. Nevertheless, these results further underscored 
the lack of requirement of the CD4 cytoplasmic domain in apoptosis signaling.
Since several lines of evidence suggested that the CD4 cytoplasmic tail does not 
play a role in the transmission of the apoptotic signal it can be envisaged that other 
domains such as the transmembrane and extracellular may play a role. The 
immunoglobulin CDR3-like region in domain 1 of CD4 has been suggested to play an 
important role in CD4 signaling (Briant et al., 1997; Cinek at al., 1995; Friedman et al., 
1996). Moreover this region, which is critical for receptor dimérisation, has been 
implicated in HIV-1 induced apoptosis. A monoclonal antibody which binds to this 
region was found to inhibit apoptosis mediated by membrane expressed HIV-1 
envelope glycoproteins (Guillerm et al., 1998). Whether this domain plays a role in the 
novel type of aCD4 induced apoptosis needs to be elucidated in future work.
Alternatively, delivery of the apoptotic signals following CD4 stimulation may 
involve a signal transduction molecule other than CD4. Thus the CD4 molecule may 
associate via its transmembrane domain another receptor or transmembrane adaptor 
molecule which then transmits the apoptotic signal. An interesting hypothesis is that the 
apoptotic signal is trasmitted by the CXCR4 receptor. In such a model CD4 could 
indirectly trigger HIV-1 induced cell death by allowing optimal interactions between 
the gpl20-gp41 and the CD4-CXCR4 complexes. In the current experimental system 
apoptosis was triggered via a monoclonal aCD4 antibody. Since there is evidence that 
association between CXCR4 and CD4 occurs to some extent in the absence of gpl20 
(Lapham et al., 1996; Ugolini et al., 1997; Kinter et al., 1998; Iyengar et al., 1998), 
although its presence enhances this association, it is plausible that stimulation of the 
CD4 receptor suffices to trigger the adjacent CXCR4 receptor. This hypothesis needs to 
be tested in future experiments.
The studies on CD4 apoptotic signaling were performed in the T cell line 
HPBALL which expresses CXCR4 but also in the CXCR4 negative B cell line BJAB 
which was stably transfected with CD4. Since chemokine receptors show great 
redundancy one cannot exclude that another chemokine receptor expressed in BJAB
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cells may compensate for the lack of CXCR4 and can also be found in close proximity 
to the CD4 receptor.
The role of mitochondria and AIF in the novel type of aCD4 induced 
apoptosis
Preliminary studies on aCD4 induced apoptosis suggested that the mitochondria 
may play a role in the execution of the caspase independent apoptotic pathway (Bemdt 
et al., 1998). This was further examined in this study and it was shown that apoptotic 
cells manifest signs of inner MMP (A'Pm dissipation) and outer MMP (release of Cyt c) 
both of which are independent of caspases.
Cytochrome c has been shown to interact with the dATP/ATP binding protein 
Apaf-1 in a reaction that leads to the autoactivation of pro-caspase-9 which then leads to 
activation of pro-caspase-3 and initiation of the caspase activation cascade (Liu et al., 
1996; Zou et al., 1997). It is therefore intriguing that although cytochrome c is released 
during aCD4 induced apoptosis caspase-3 and -8 are not activated and the cell death 
pathway is not inhibitable by the pancaspase inhibitor zVAD-fink (Bemdt et al., 1998). 
One plausible explanation for this apparent paradox is that the energy status of the 
apoptotic cell may determine the activation of caspases. It has been previously shown 
that the complete apoptotic programme involves energy requiring steps, one of wich 
may be at the level of the formation of the protein complex between Apaf-1, cyt-c and 
procaspases (Eguchi et al., 1997; Leist et al., 1997). Further pulsed ATP 
depletion/repletion experiments are needed in order to determine whether a certain 
energy threshold dictates the activation of caspases in this experimental system.
Alternatively, although inhibitory peptides such as zVAD-fmk are considered 
specific for the caspase family they may in fact block only some, but not all caspases. 
Therefore it cannot be excluded that so far unknown caspases or other proteases may be 
activated following cyt-c release.
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The caspase independent effector of apoptosis AIF was also shown to be 
released from the mitochondria during aCD4 induced apoptosis. Moreover large scale 
DNA fragmentation was observed which has been previously correlated with AIF 
translocation to the nucleus (Susin et al., 1999). Paradoxically, formation of large DNA 
fragments was inhibited by zVAD-fmk. Although in a cell free system and in 
fibroblastic cell lines AIF causes caspase independent large scale DNA fragmentation 
and peripheral chromatin condensation (Susin et al., 1999; Daugas et al., 2000), in 
HIV-1 induced HeLa syncytia the formation of large DNA fragments appears to be fully 
caspase dependent (Ferri et al., 2000). Therefore, it seems that AIF acts in a cell type 
specific manner and it remains unclear whether AIF inhibitory factors and/or the 
abundance of the nuclear AIF target may account for these differences.
Whatever the case may be further experiments are needed using AIF blocking 
agents in order to prove that AIF is an effector of aCD4 induced apoptosis. Moreover, 
kinetic analysis of AIF release and nuclear morphological alterations should be 
performed. In the present experiments AIF translocation was evaluated one hour 
following CD4 stimulation while large scale DNA fragmentation was evaluated at later 
time points (3 and 10 h). Since aCD4 induced apoptosis proceeds very rapidly the 
nuclear fragmentation pattern seen could be due to unspecific activation of caspases 
secondary to apoptosis.
Kinetic analysis and blocking experiments of cyt-c release should also be 
performed in the present system, in order to establish an hierarchy of events and define 
the relative contribution of the mitochondrial factors to apoptosis induction. It has been 
previously shown in other systems that AIF release precedes that of cyt-c even by 
several hours (Ferri et al., 2000; Daugas et al., 2000). Since microinjection of 
recombinant AIF induced MMP and cyt-c release, a caspase independent amplification 
loop induced by AIF was suggested (Ferri et al., 2000). It is plausible that AIF is rapidly 
released following CD4 triggering; thus favoring a caspase independent effector 
pathway; while cytochrome c is released once the cell is in the „commitment“ phase. 
Therefore, even if caspases are activated at that stage, the caspase independent effector 
pathway may be dominant.
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Conclusions
The work described in this thesis aimed at investigating the role of CD4 and 
CXCR4 induced apoptosis as a potential indirect mechanism of T-cell depletion during 
HIV-1 infection. The finding that PBLs from HIV-1 infected individuals were sensitive 
to CD4 and CXCR4 mediated apoptosis suggests a role for this phenomenon in HIV-1 
disease pathogenesis. Depletion of CD4+ T cells by such a mechanism is most probably 
due to the hyperactivation of the immune system seen during the course of the infection. 
The fact that healthy PBLs could be sensitized , via activation, to undergo CD4 and 
CXCR4 mediated apoptosis further supports this hypothesis.
Another aim of the work was to investigate the relative contribution of the 
„classical“ or „novel“ apoptotic pathways engaged by the CD4 and CXCR4 receptors, 
upon cell death induction, in the in vivo situation. Both pathways were found to be 
involved, however, the novel caspase independent cell death pathway was the 
predominant one.
The work also aimed at investigating some of the signaling events involved in 
the „novel“ type of apoptosis triggered by the CD4 and CXCR4 receptors. Studies on 
CXCR4-CXCR2 receptor chimeras revealed that the first and second intracellular loops 
of the CXCR4 receptor are probably critical for the propagation of the apoptotic 
stimulus. Studies on CD4 mutant receptors showed that the cytoplasmic tail of CD4 is 
dispensable for the induction of cell death. Preliminary biochemical analysis also failed 
to detect recruitment of signaling molecules to the CD4 receptor complex. These 
findings thus suggest that a molecule adjacent to the CD4 receptor or the CXCR4 
receptor may be responsible for the transmission of the apoptotic signal. Studies on the 
role of mitochondria during CD4 mediated apoptosis showed release of both 
cytochrome c and AIF. This suggests a central role for mitochondria in the CD4 
induced, caspase independent apoptotic signaling pathway.
Improvement of our understanding of the mechanisms of HIV-1 associated 
lymphocyte apoptosis, as well as the signaling cascades involved, may lead to
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therapeutic strategies aimed at intervening with the CD4+ T cell depletion in HIV-1 
infected individuals.
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VI Abbreviations
# number
a
Tm
AYm
X
m
Ml
|iM
anti-
mitochondrial transmembrane potential
mitochondrial transmembrane potential reduction
wavelength
microgramm
microlitre
micromolar
Ah
AICD
AIDS
AIF
Act D
APS
Ag
ATP
Bcl-2
BD.fmk
bp
BSA
CD95L
CCR
CD
cDNA
Ci
antibody
activation induced cell death 
acquired immunodeficiency syndrome 
apoptosis inducing faktor 
actinomycin D 
ammonium Peroxide sulfate 
antigen
adenosine triphosphate 
B cell lymphoma
t-butoxy carbonyl-Asp.fluoromethylketone 
base pair
bovine serum albumin
CD95 ligand
C-C-chemokine receptor
cluster of differentiation
complementary deoxyribonnucleic acid
Curie
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CIAP
CrmA
CTL
CXCR
Cyt-C
Da
DD
DED
DEE
DISC
DiOC6(3)
DMSO
DNA
ECL
E.coli
EDTA
env
ERK
FACS
FADD
FCS
FITC
FL
FLICE
fmk
ESC
gP
h
HIV-1
HPBALL
HRPO
ICE
IFN
calf intestinal alkaline phosphatase
cytokine response modifier A
cytotoxic T cell
C-X-C chemokine receptor
cytochrome c
Dalton
death domain
death effector domain
DNA fragmentation factor
death inducing signaling complex
dihexyloxacarbocyanine iodide
dimethylsulfoxide
deoxyribonucleic acid
enhanced chemiluminescence
Escherichia coli
ethyl diamine tetra-acetate
envelope
extracellular signal related kinase
fluorescence-activated cell sorter
Fas-associated death domain protein
fetal calf serume
fluorescein isothiocyanate
fluorescence
FADD-like ICE
fluoromethyl ketone
forward scatter
glycoprotein
hour
human immundeficiency virus 1
human peripheral blood acute lymphatic leukemia
horse raddish-peroxidase
Interleukin-Ip-converting enzyme
Interferon
Abbreviations
Ig Immunglobulin
IL Interleukin
kDa kilodalton
kb kilobase
Ick lymphocyte specific protein tyrosine kinase
LT lymphotoxin
LZ Leucine-Zipper
M molar
MAPK mitogen-aktiviated protein kinase
MHC major histocompatibility complex
MFI mean fluorescence intensity
MIP macrophage inflammatory protein
min. minute
ml mililitre
mM milimolar
MMP mitochondrial membrane permeabilisation
MORTl mediator of receptor-induced toxicity 1
M-tropic macrophage tropic
MW molecular weight
NK cells natural killer cells
NO nitric oxide
NSI non syncytium inducing
CD optical density
PARP poly-(ADP-ribose)-polymerase
PEL peripheral blood lymphocyte
PBMC peripheral blood mononuclear cells
PBS phosphate buffered saline
PCR polymerase-chain reaction
PE phycoerythrin
PHA phytohemagglutinin
PKC Proteinkinase C
PMA phorbol-12-myristate-13-acetate
PMSF phenylmethylsulfonylfluoride
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PT
RANTES
rpm
RT
SDS-PAGE
sec
SDF-1
SDS
src
SSC
t
TBE
TCR
TNF
TNF-R
TRAF
TRAIL
TRAMP
T-tropic
UV
v/v
v/w
zVAD.fmk
permeability-transition
regulated upon activation, T-expressed and secreted 
rounds per minute 
room temperature
Natriumdodecylsulfat-Polyacrylamid-Gelelektrophorese
second
stromal cell-derived factor 1 
sodium dodecyl sulfate 
sarcoma virus protein kinase 
side scatter 
time
Tris-borate-EDTA
T-cell-receptor
tumor necrosis factor
tumor necrosis factor-receptor
TNF receptor associated factor
TNF-related apoptosis-inducing ligand
TNF receptor-related apoptosis mediating protein
T cell tropic
ultraviolet
volume per volume
volume per weight
B enzyloxy carbonyl-V al-Ala-Asp-(0-methyl)-fluoromety 1 ketone
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